Modification of Lipid Microenvironments on Solid Support Structures for Use in Transmembrane Protein Assays by Houlihan, William J
City University of New York (CUNY)
CUNY Academic Works
Dissertations and Theses City College of New York
2019
Modification of Lipid Microenvironments on Solid
Support Structures for Use in Transmembrane
Protein Assays
William J. Houlihan
CUNY City College
How does access to this work benefit you? Let us know!
Follow this and additional works at: https://academicworks.cuny.edu/cc_etds_theses
Part of the Biochemical and Biomolecular Engineering Commons, Biological Engineering
Commons, Biomaterials Commons, and the Molecular, Cellular, and Tissue Engineering Commons
This Dissertation is brought to you for free and open access by the City College of New York at CUNY Academic Works. It has been accepted for
inclusion in Dissertations and Theses by an authorized administrator of CUNY Academic Works. For more information, please contact
AcademicWorks@cuny.edu.
Recommended Citation
Houlihan, William J., "Modification of Lipid Microenvironments on Solid Support Structures for Use in Transmembrane Protein
Assays" (2019). CUNY Academic Works.
https://academicworks.cuny.edu/cc_etds_theses/771
  
 
 
 
 
 
Modification of Lipid Microenvironments on Solid 
Support Structures for Use in Transmembrane 
Protein Assays 
 
 
 
 
 
 
 
By William J. Houlihan 
 
 
 
Research Mentor: M. Lane Gilchrist 
Department of Chemical Engineering 
The City College of New York 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation Submitted to the Graduate Faculty in Engineering in Partial 
Fulfillment of the Requirements for the Degree of Doctor of Philosophy 
 
March 2019 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2019 
William J. Houlihan 
All Rights Reserved 
iii 
 
This manuscript has been read and accepted for the Graduate Faculty in Engineering in 
satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. 
 
 
 
 
___________________                  _________________ 
M. Lane Gilchrist, Chair of Examining Committee     Date 
 
 
 
 
___________________ ______________________________     
Ardie D. Walser, Associate Dean for Academic Affairs   Date 
 
 
 
 
 
 
 
 
Professor M. Lane Gilchrist, Mentor, Department of Chemical Engineering 
Professor Ilona Kretzschmar, Department of Chemical Engineering 
Professor Raymond Tu, Department of Chemical Engineering 
Professor Charles Maldarelli, Department of Biomedical Engineering 
Dr. Yueming Li, Memorial Sloan-Kettering Cancer Center 
 
Examining Committee 
 
 
 
THE CITY COLLEGE OF NEW YORK 
iv 
 
Abstract  
 Gamma-Secretase (γ-secretase) is a transmembrane protease of increasing interest, which 
has been shown to have significant connections to both cancer and Alzheimer’s disease.  γ-
secretase cleaves both Notch-1, a transmembrane signaling protein, and Amyloid precursor 
protein (APP), a transmembrane protein whose cleavage may result in the formation of β-
amyloid plaques in the brain.  Notch-1 and APP are widely studied proteins that have substantial 
impacts on the development and proliferation of cancer and Alzheimer’s disease, respectively.  
Notch-1 partakes in the signaling of apoptosis in damaged and mutated cells, thus its cleavage by 
γ-secretase within the plasma membrane has ramifications on cell growth and proliferation. 
However, the APP molecule is the key protein in the metabolic pathway that produces small 
amyloid fragments.  These fragments, in undesirable conditions, have the propensity to aggregate 
and form, as stated above, amyloid plaques, depending on the fragment length.  These plaques 
have been long believed to inhibit neuronal function if they are not degraded or removed from 
the intracellular space, specifically in the brain. 
Due to these widespread mental and physical health impacts, isolation and modulation of 
the cleavage of such proteins in intact, controlled bilayers in a highly reproducible, and 
potentially high-throughput, process is a key goal in understanding these and a vast array of 
intramembrane proteases for the development of pharmaceutical therapies.  The work presented 
looks to the development of one such platform, yielding crucial spatial and temporal information 
within these complex lipid microenvironments.  Synthetic, biomimetic membranes were studied 
and manipulated to develop biologically relevant systems in which to resuspend isolated 
proteins.  A formulation of sphingomyelin, 1,2-Dioleoyl-sn-phosphatidylcholine (DOPC), and 
cholesterol was chosen due to its attributes in resembling fundamental lipodomics within a 
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human brain cell.  It is shown that this canonical formulation and subsequent formulations with 
added complex mixtures, yield a lipid system that retains visible phase separation to a 
quantifiable degree.  These lipid formulations, when fused with solid silica support structures 
such as planar surfaces or silica microbeads, allows for the reconstitution of the three of proteins 
of interest. 
These assay and high throughput platforms are essential to understanding key functions 
and potential modulations of these protein pathways, however this approach does not fully 
replicate the biological environment these proteins experience within an active cell.  Two 
approaches are shown in this work to increase the biological relevancy of these platforms.  
Tethering of the solid support structures with a series of polyethylene glycol (PEG) polymers 
culminating in a functionalized capping moiety that can yield overall increases to protein 
mobility, and added functionality of the platform.  Additionally, added dopants of more complex 
lipid components into the basic lipid membrane analogue shows the ability to increase 
complexity of the formulation and closes the gap between the synthetic membrane and the 
protein’s true biological lipid environment. 
These platforms are highly robust and rugged in nature and lend themselves to be useful 
in future high-throughput screening and functional assay processes in pharmaceutical research.  
The coupling of both planar surface support structures and micro bead structures in tandem can 
be analyzed through confocal, super-resolution, and atomic force microscopy, leading to a fuller 
understanding of these complex spatial reaction-diffusion systems prevalent within human cells. 
The systems developed in this research, apart from being tested with the aforementioned 
proteins, are not protein-specific and thus could yield a viable platform on which to test any 
number of isolated transmembrane proteins in a highly reproducible manner.  
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Preface 
 The intent of this thesis is to develop and expand the field of potential viable protein 
assay and analysis platforms due to their large potential as drug and therapy targets in the 
pharmaceutical industry.  The experiments chosen in this work were chosen to exemplify the 
utility and potential uses of in tandem studies performed on both planar supported bilayers and 
proteolipobead constructs, as well as the use of atomic force microscopy and confocal 
microscopy to yield a well-defined and characterized, and modular high-throughput solution for 
further protein analysis.  A major theme of the work presented throughout this research is the 
flexibility of a modular approach, developing base systems that can be made more complex or 
more functional at the future researcher’s behest.  Flexibility in these systems yields a wider 
impact potential on the viability and function as a protein analysis platform.   
 Chapter 1 begins by introducing the systems and platforms developed over the course of 
this study, and the biological relevancy and importance of the specific proteins analyzed in this 
work.  The focus here being to elucidate the approach to developing biologically relevant assay 
and analysis platforms which can be used in high-throughput screening testing to better 
understand the intricacies and functions of these proteins.  The methods of characterization and 
study used in this work are introduced to lay the foundation on which the claims in the results 
and conclusions are developed. 
 Chapter 2 provides the approach and modifications developed on the basis of a 
canonically used lipid membrane formulation for the study of proteins in supported lipid 
bilayers, both on planar supports and microbead systems.   Sphingomyelin (SM), 1,2-Dioleoyl-
sn-glycero-3-phosphocholine (DOPC), and Cholesterol are combined here to for a well-studied 
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brain cell membrane analogue.  This analogue, while useful, still lacks in fully capturing the 
cellular lipid environment, and thus more complex mixtures and dopants were added to increase 
the system’s overall biological relevance.   Chapter 3 is the core protein work of this research.  
This chapter gives the account of using these biologically analogous lipid formulation in order to 
develop and express γ-secretase and two of its known substrates, derived from Notch-1 and the 
Amyloid precursor protein.  These three proteins are shown to be reconstituted in both the planar 
supported bilayer, as well as the lipobeads construct yielding a tandem approach to 
characterization, functional assays, and high-throughput analysis and testing. 
Chapter 4 presents the work performed in developing functional polymers tethering 
supports structures on the surface of the solid support structures.  By using a series of relatively 
simple ester-linkage chemistries, a solid surface can be fully coated with a modular polymer 
support structure to help provide further functionality in assays and analysis of these biomimetic 
systems as well develop a system that more closely resembles the mechanical properties of the 
biological environment which is trying to be mimicked.  The process shown here is 
straightforward and modular in an attempt to create a basis for a system that can afford a host of 
functionalities rather than one static system. 
 Finally, the overall conclusion and claims made in this work are summarized in chapter 5 
along with any future works possible to further ratify claims or answer questions raised by this 
research. 
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Chapter 1. Introduction 
 I. Motivation 
 High throughput screening has become a staple in the study of chemical therapeutics and 
pharmacology[1]–[3].  This is a process by which large quantities of chemical species are tested 
for their efficacy in order to eliminate species with low efficiency or some level of toxicity, as 
these characteristics make for a poor therapeutic or commercial drug.  High throughput screening 
is an ideal technology for the drug and pharmaceutical industry, as it allows for high volume 
testing, for low effective cost, and it simultaneously eliminates the need to further study 
compounds with little to no efficacy and push them through costly FDA approval trials.[4], [5]  
Microbead and particle-based high throughput screening has gained a prominent foothold within 
this field, as to harness the power of flow cytometry[6].    
 Transmembrane proteins are currently a class of proteins with which high throughput 
screening techniques have only been used for approximately 10-15 years. These proteins are 
difficult to isolate and test while maintaining similar levels of functionality as found in cell 
studies.  The main difficulty with this category of protein arises from its necessity to be 
suspended within a cell membrane, due to its amino acid structure creating a sizeable 
hydrophobic domain, which in cells sits within the confines of the plasma membrane.  Cell 
studies are time and money intensive due to the necessary genetic modifications required to 
isolate and explore singular protein pathways, however this is the most common screening 
method for transmembrane proteins at the present. 
 It is thus desirable to develop a platform on which transmembrane proteins can be 
reconstituted, while maintaining cellular levels of functionality in a highly controlled and 
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reproducible manner.  Under these constraints, a process has been developed to engineer 
synthetic plasma membranes, fuse them to solid support structures, and reconstitute a 
transmembrane protein known as γ-secretase into these membranes along with two of is 
substrates in order to test key metrics that associate with function in in vivo studies[7]. Namely 
these metrics include lipid microenvironment, diffusion, partitioning, and enzyme activity. 
 II. Plasma Membranes 
 The study of plasma membranes, or lipid bilayer, has been an ongoing pursuit for many 
generations [8].  A lipid bilayer is formed when molecules with a hydrophilic head group 
attached to a hydrophobic tail, known as a lipid, begin to self-assemble in aqueous solutions as a 
way to minimize their free energy.  The lipids self-assemble into double sided sheets with the 
hydrophobic tails towards the center and the hydrophilic head groups jutting out into the water, 
called lamella. 
Since the identification of the cell and its constituents, lipid bilayers have been known to 
play an important role in many biological functions with the main functional unit arising in the 
form of the cell membrane. The cell membrane is considered to be a fluid mosaic [9]. This 
means that while it can be considered a solid barrier for some large molecules, it is actually 
mobile and comprised of numerous mobile moieties including, proteins, lipids, and sugar[10], 
[11].  These mobile units give the membrane its structure and function creating highly complex 
intertwining networks which are the root of various cell processes.   It is this quality of the cell 
membrane which makes it an interesting topic of study.   
In recent year, the hypothesis of lipid raft formation has been a hotly debated topic 
between lipid membrane researchers[9], [12], [13]. The lipid raft theory states that small, 
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sometimes nano-scale gradients of lipid species occur throughout the confluent bilayer of the 
plasma membrane, and that these spatial gradients are an active player in cellular dynamics[14]–
[16].  Recent studied into cell lipid fractions using lysed cells dissolved in detergent show that 
two regimes exist within cell plasma membranes, a more rigid and viscous regime, known as the 
liquid ordered domain, and a less detergent resistant, more mobile, liquid disordered domain[17]. 
This work was further confirmed through the use of NMR, as these studies are what gave rise to 
the distinction of the liquid ordered versus disordered phase as the order and disorder are a 
reference to lipid acyl chain order parameters of lipids within the phases[18]–[20]. These 
cholesterol-rich microdomain are thought to be thicker and more viscous than the liquid 
disordered phase[21]–[23].  Cellular lipodomics reveal a multitude of lipids present in the entire 
cellular lipid biome, reaching levels of 10,000+ individual species within a single cell[24].   This 
large array of lipids found in the cellular biome makes the domain structure practically 
unresolvable under most common imaging methodologies.   
Synthetic lipid bilayers have been developed in various forms as a stable yet dynamic 
system for understanding some high level cellular functionality like cell to cell interactions, 
integral membrane protein function, and microenvironment changes [25]–[28].  A large push in 
the study of lipid bilayers is in the form of studying giant unilamellar vesicles (GUVs), giant 
plasma membrane vesicles (GPMVs), and proteoliposomes [29]–[34].  These systems are widely 
used due to their ease of formation, and are helped by the fact that GUVs and GPMVs are easy to 
image due to their large size.  However, they have some drawbacks when it comes to their 
versatility in experimentation as these systems are not very robust as a testing platform due to 
their susceptibility to puncture, cavitation, and inherently have no support structure.  Due to the 
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lack of support, a new platform was developed to create a more robust system that resists 
deformation while maintaining native levels of bilayer fluidity. 
Supported lipid bilayers have been used as membrane mimics for a handful of years now 
[35]–[37].  The most common form of supported lipid bilayer is the planar bilayer, which is 
created through one of two procedures.  The first method is through the use of a Langmuir-
Blodgett trough, when a hydrophilic material is coated with the lipids a single layer at a 
time[38]–[40].  The Langmuir Blodgett approach allows for an added level of control over each 
layer deposited onto the hydrophilic surface, and this control has the potential to form 
asymmetric lipid bilayers.  Asymmetric lipid bilayers, commonly found in biological systems, 
are bilayers forced into a state of non-equilibrium in which each leaflet of the bilayer has a 
varying composition of lipids[41]–[44].  Asymmetric bilayers are difficult to maintain in situ as 
most supported lipid systems tend towards an equilibrium between both leaflets of the bilayer as 
well as all molecular species within the bilayer. 
  The more common method is through lipid vesicle adsorption onto the hydrophilic 
surface, in which a suspension containing unilamellar vesicles is exposed to the hydrophilic 
surface for a desired time[45]–[48].  The vesicles deform and rupture on the hydrophobic surface 
and reform into a confluent lipid bilayer.  Planar bilayers are useful for the study of many 
systems due to the rigidity of the material and the ability to deposit the bilayer directly onto a 
microscope glass slide or coverslip.  Secondly, the planar hydrophobic surface affords the added 
ability to functionalize and augment parts or all of the solid surface, giving rise to added levels of 
control and versatility in the lipid platform[46], [49]. 
There is a drawback to these planar supported lipid bilayers in the characteristic that these 
platforms are two dimensional.  In some cases a three dimensional approach is beneficial as it 
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allows for a more precise mimic of the biological system in the case of cellular interactions with 
these types of platforms.  To this end, a three dimensional platform has been developed in the 
form of a spherical bead which is used as the solid support for the lipid bilayer.  This lipobeads 
(LB) is a lipid bilayer suspended on the surface of a hydrophilic surface much in the same way as 
the planar bilayer is suspended in the planar bilayer system[50]–[53].  The LBs can be formed 
through normal adsorption of vesicles onto the surface, or through a Langmuir Blodgett approach 
as well.  The beads, much like the hydrophilic surface in the planar system, can also be 
functionalized to yield a higher level of control and versatility to the 3D platform, including 
integrating wash steps to remove excess membrane proteins and lipids that could give artifacts.  
Furthermore, this format is amenable to flow cytometric analysis and screening. 
 III. Transmembrane proteins 
 Soluble and transmembrane proteins make up 2-4 million molecules per cubic micron of 
the mammalian cell, and a large subspecies of these proteins are integral, or transmembrane 
proteins (TMPs) [54], [55].  These proteins span the width of the plasma membranes within cells 
and perform many tasks ranging from transport, to cell signaling, as well as housekeeping 
functions.  Many of the larger protein structures such as aquaporin, an integral membrane protein 
which allows for a large flux of water to travel through the membrane, have been studied intently 
over the years [56]. Though, this work only scratches the surface of the entire class of TMPs 
available for study as these proteins are difficult to study and understand due to their complex 
nature and steep requirement for a fluid bilayer to remain functionally viable.  Most integral 
membrane proteins lose functionality when removed from the confines of a lipid bilayer, also 
aggregation of hydrophobic domains and denaturation occurs with these proteins when they are 
no longer stabilized by a confluent lipid bilayer or by detergents.  It has also been shown that the 
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surrounding environment has effects on protein function, the environmental effects could be due 
to a global effect of the homeostasis of the biological system or could arise from small micro or 
nano environmental changes within the lipid bilayer, such as lipid bilayer thickness changes and 
raft formation or dissipation[57]–[59].  In systems comprised of multiple protein interactions and 
pathway triggers, orientation of the protein within the bilayer is another important factor which 
can confound the study of these proteins outside of the cell structure.  As in cells, this expression 
and insertion into the cell membranes is facilitated through a series of chaperone proteins helping 
during transcription. 
 Current TMP studies rely heavily on recombinant cell and bacterial culture studies, in 
which eukaryotic or prokaryotic cells are genetically modified to over express these proteins or 
to suppress the expression of other proteins in order to isolate a single TMP system.  These 
studies are long, difficult, and expensive while also plagued with a sense of uncertainty[60]–[63].  
Cell and bacterial cultures are incredibly dynamic and complex systems which are still not yet 
fully understood in some cases [64].  Many metabolic and signaling pathways have not been 
completely mapped as of this time, while other pathways which are understood have multiple 
levels of redundancies built into them in order to maintain cell viability in the absence of a 
molecular pathway [65].  These built in redundancies and failsafe pathways have been developed 
over hundreds of thousands of years of evolution in some cases and are thus very hard to account 
for in these types of assays. 
 A desirable assay for integral membrane protein study must include the ability to isolate 
the interesting proteins and its substrates, proper environmental control of the lipid or 
homeostatic system, and proper orientation control of the protein in native cellular formats. 
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IV. Gamma Secretase and its Substrates 
 A subset of these integral membrane proteins is a class of cleavage enzymes known as 
intramembrane proteases, and one in particular is of paramount interest.  γ-secretase is a cleavage 
enzyme found throughout mammalian biological systems, it is a protease which cleaves other 
TMPs at an active site located within the hydrophobic domain of the lipid bilayer shown in 
figure 1.1.[66]  There are two proteins of interest which this enzyme is known to cleave, one 
being the amyloid precursor protein (APP) and the second being the protein Notch-1 shown in 
figure 1.2. Both of these substrates are interesting because they are believed to hold a role in the 
development of Alzheimer’s disease and the proliferation of cancer cells, respectively [67], [68].   
γ-secretase is a large integral membrane protein on the order of 170 kDa, with multiple 
transmembrane helixes and extracellular domains.  -Secretase is an enzymatic complex 
composed of at least four proteins: presenilin 1 or presenilin 2 (PS1 or PS2), Nicastrin, Pen2 and 
Aph1, with presenilin representing the catalytic core.  In 2015, a 3.4 Angstrom resolution cryo-
EM structure of the enzyme was obtained, and further structures have been obtained showing the 
protein in an active configuration[69]–[72].  This discovery has given insight into the function 
and processes of this enzyme, but native configuration testing has not yet been completed. 
 
Figure 1.1 γ-secretase structure and domain distribution.  This is a representation of the full γ-
secretase structure as seen in the PDB file 5a63.  Panel A Shows the γ-secretase protein positioned within 
a confluent lipid bilayer. In panel B the γ-secretase molecule is colored to represent the different charge, 
hydrophilic, and hydrophobic domains. Panel C displays the isolated γ-secretase shown here exposing the 
sizeable hydrophobic domain displayed in white.  
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Figure 1.2 APP and Notch-1 substrate structures.  Panel A here is a truncated structure of the APP 
known as C99 (PDB: 2LP1) as it is 99 amino acid residues long. The arrow here indicates the cholesterol 
binding domain found in the APP structure which is suggested to effect partitioning and diffusion of the 
protein. Panel B shows the Noth-1 signaling protein structure (PDB: 5KZO) 
 The APP substrate is cleaved by γ-secretase within the cell membrane, but the cleavage 
specificity and efficiency are unknown outside of the fact that this cleavage can create 2 distinct 
byproducts and the productions of these fragments can be correlated to cholesterol content [73]–
[75].  One byproduct of this cleavage is a harmless protein fragment which can be further 
digested and recycled into the cell, while the second possible byproduct is the formation of an 
amylogenic protein fragment which cannot be further digested by the cell or other biological 
enzymes.  This second amylogenic protein has the propensity to form amyloid aggregates which 
can grow into amyloid plaques[76]–[78].  Amyloid plaques that form in the brain can disrupt 
neuronal function and health, resulting in the possible development of neurodegenerative 
diseases such as Alzheimer’s, dementia, and potentially many others.  These different byproducts 
are a result of a switch in cleavage position along the peptide strand, called cleavage specificity.  
The efficiency of γ-secretase is related to the enzymatic rate of the cleavage.  As stated above, it 
has been shown that cholesterol plays a significant role in determining the cleavage specificity of 
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γ-secretase, though it is unknown whether this effect is due to a global increase of cellular 
cholesterol concentration or micro/nano environmental effects which arise from a higher 
concentration of cholesterol in the lipid bilayer.   
  Notch-1 Is a cell signaling protein [68], [79], [80].  Notch proteins are well known to 
contribute to cell proliferation, differentiation, and apoptosis. Healthy cells express an activated 
form of Notch-1, it is believed that γ-secretase cleavage is the activation step of the Notch-1 
protein.  When γ-secretase is blocked, Notch-1 cleavage and activation also becomes blocked 
causing the cell to signal for apoptosis.  When healthy cells are damaged or begin to function 
improperly, signals are released which block the enzymatic capabilities of γ-secretase, thus 
causing a cascade effect leading to the destruction and apoptosis of the unhealthy cell.  It has 
been shown however that in some cancerous cells, these damage signals are suppressed and thus 
γ-secretase continues to activate Notch-1 as it would during healthy cell function.  This leads to 
the proliferation of cancerous cells in the body and potential tumorigenesis[73], [81], [82]. 
 Understanding the function and enzymatic rate of γ-secretase and its substrates in these 
two systems could hold the key to a fuller understanding of these diseases and potential 
therapies. 
V. Microscopy 
 Light microscopy is a well-defined and widely used experimental tool[83].  A key feature 
of light microscopy is the idea of fluorescence microscopy. Fluorescent molecules are molecules 
that can absorb the energy of certain wavelengths of light, this absorption is used as energy to 
cause electronic transitions between energy levels within the molecular structure.  This excited 
electron state only lasts a brief period of time however, and when the system returns to ground 
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state, the energy release by the system has been diminished slightly and is released as a red 
shifted photon.  This means a fluorescent molecule can absorb light at one wavelength and emit 
light at a longer, lower energy wavelength.  Light microscopy and fluorescence can be used in 
conjunction in another imaging technique named confocal scanning light microscopy 
(CSLM)[84], [85].  This imaging modality was developed as a method to visualize 3D structures 
from a 2D imaging modality.  CLSM uses a double pinhole set up in which the position of the 
pinholes can be tuned in such a way that the photon detector only captures light from a specified 
focal plane through the sample at a specific voxel.  A series of images can be taken by adjusting 
the pinholes to focus on discreet neighboring focal planes, then the images can be combined with 
computer software to produce a 3D image of the sample[86]. 
 Light and confocal microscopy have been used extensively as an imaging modality in 
biological systems since light microscopy is one of the few methods which does not require  
sample fixation, and can be performed on a live cellular sample.  With the correct choice of 
fluorophores, the entire internal structure can be viewed in real time, and with this method, real 
time assays can be performed on active systems.  The correct choice of fluorophores is an 
important aspect of fluorescence microscopy ever since the development of the Forster resonance 
energy transfer (FRET) technique of imaging [87], [88]. FRET is the process by which a single 
fluorophore, is raised to the excited state but rather than release this energy as a photon, the 
donor fluorophore pairs with an acceptor within a threshold distance and undergoes an energy 
transfer due to a resonant coupling. The second fluorophore then relaxes to ground state, 
releasing a photon of light[88].  This transfer of energy not only occurs between two 
fluorophores whose emission and excitation overlap, but it also only occurs when these two 
fluorophores are within a specific distance from one another. The intensity of the emitted light 
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from the second fluorophore can be used to calculate the distance between the donor and 
acceptor at the time of imaging.  This technique has helped understand the spatial separation of 
molecules and biological moieties in countless studies[88]–[94].    
Biological systems are difficult to study in other forms of microscopy such as electron 
microscopy as the bombardment of the sample with a high powered electron beam causes serious 
damage to live cells and in some cases cannot even be performed on live samples.  Yet this 
imaging modality comes at a cost of resolution.  Light microscopy uses light in the visible, and 
near visible, spectrum in order to create images, and thus the possible resolution of these images 
is handcuffed to the wavelength of visible light.  The resolution of images taken with light 
microscopy is on the order of >200 nanometers, while electron microscopy can reach resolution 
limits of <2 nanometers.  As stated above, cellular structures and membrane domains can be on 
the order of 1-2 nanometers, and the lipid bilayer itself is approximately 4 nanometers thick 
depending on lipid composition.  Light microscopy is limited by Abbe’s diffraction limitation 
which is shown in equation 1, meaning that resolution is directly proportional to wavelength of 
light detected and the limits of the mechanical system (numerical aperture, refractive index, etc.). 
𝑑 =
𝜆
2 ∗ 𝑛 ∗ sin⁡(𝛼)
⁡⁡[1] 
In the past 5 years, new imaging modalities have emerged within light microscopy.  In 
2014, Stefan Hell, Eric Bertzig, and William Moerner won the Nobel Prize in chemistry for the 
development of a light based imaging technique which breaks the law of Abbe’s diffraction 
limitation, and their work in single molecule microscopy.  This imaging technique is called 
STimulated Emission Depletion (STED)[95]–[97]. This new technology uses a 2 beam system in 
which the excitation light travels through the sample as normal, while a second wavelength of 
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light, tuned to emission spectra of the imaged fluorophore is modulated as a ring around the 
excitation beam.  This depletion “donut” quenches all of the fluorescence caught within the ring, 
and thus only a small focal point emits any light to the detector.  Through this method of 
imaging, the resolution limit of light microscopy is able to reach approximately 50 nm, a shift of 
about one order of magnitude greater resolution in live systems[96].  However, this method 
cannot be ubiquitously implemented as the fluorophores applicable to this modality are limited 
and specific.   
Similarly in 2014 a second approach to this question of super resolution light microscopy 
was developed and implemented by Zeiss[98], [99].  This procedure was named Airyscan, and 
this modality to super resolution yields resolutions of 140 nm laterally and 400nm axially, about 
2-3 times less specific than the STED, but the Airyscan method is not restrictive in usable 
fluorophores[100].  The Airyscan method consists of using an array of pinholes in lieu of a 
single pinhole for imaging.  This array allows for the detection of particle “movement” as a 
function of the laser scanning aspect of confocal, where the object does not move but rather the 
moving laser light during the scan illuminates the fluorophore in a quantifiably different 
orientation during the course of the scan.  Due to the location and layout of the pinhole array, this 
allows for the reflected light to only pass through certain pinholes depending on the orientation 
of the laser illumination which allows for a recombination of the pinholes images to produce a 
super resolution image. 
The final approach to microscopy for this work is Atomic Force Microscopy 
(AFM)[101]–[103].  AFM is an experimental modality with a variety of potential uses.  A small 
functional probe is positioned to reflect a laser light onto a specialized detector, modulations in 
the probe tip cause the laser reflection to move along the detector and this movement is 
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quantifiable as a deflection from a normalized position.  Understanding and testing the material 
characteristics and shape of the AFM probe tip allows for a variety of calculations to be made 
about the sample being tested.  Attractive, repulsive, indentation, and extraction forces can be 
obtained from samples through the use of force curves. AFM also allows for the development of 
an effective image of the sample being tested.  AFM tapping or constant contact mode both 
produce a type of image over a small scanned area.  By measuring the probe tip deflection over a 
small area, an effective 2D height analysis image can be developed.  These images have a 
relative resolution limit below 1 nm.  This resolution limit is effected by the shape and design of 
the probe tip, and the accuracy of the photodiode detector. 
A combination of the aforementioned microscopy modalities can be used in tandem in 
order to develop nano and micron scale characterizations of samples and platforms described 
herein. 
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VI. Tables  
Table 1.1. List of Materials and Molecular structures. 
Materials 
Name Atomic Structure Properties 
Cholesterol 
 
Sterol molecule 
used in all sample 
formulations 
Brain Polar Lipid Extract 
(BPLE) 
N/A lipids extract used 
as majority 
component of 
biomimetic 
system 
L-α-Phosphatidylcholine (PC) 
 
Purified lipid used 
in the biomimetic 
system  
Sphingomyelin (SM) 
 
Liquid ordered 
mimic lipid used 
in minimalist 
formulation 
1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) 
 
 
liquid disordered 
mimic lipid used 
in minimalist 
formulation 
1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) 
long chain 
saturated lipid 
molecule for use 
in cancer lipidome 
tests 
1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) 
 
long chain 
saturated lipid 
molecule for use 
in cancer lipidome 
tests 
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3,3'-
Dihexadecyloxacarbocyanine 
Perchlorate (DiO) 
 
Lipophilic 
fluorescent tracer. 
Excitation/Emissi
on: 488/506 
1,1'-Dihexadecyl-3,3,3',3'-
Tetramethylindocarbocyanine 
Perchlorate (DiI) 
 
Lipophilic 
fluorescent tracer. 
Excitation/Emissi
on: 551/570 
Streptavidin-AlexaFluor 660 
(SA660) 
N/A Protein 
fluorescent tag. 
Excitation/Emissi
on: 660/690 
(3-
Aminopropyl)trimethoxysilane(
APS) 
 
amino silane used 
in silica 
modification 
bis(sulfosuccinimidyl)suberate 
(BS3) 
 
zero-length cross 
linker 
Polyethylene Glycol (PEG)  
 
Polymer spacer 
N-hydroxysuccinimide- PEG4- 
Biotin (NHS-PEG4-Biotin) 
 
tethering moiety/ 
streptavidin 
functionalization 
N-hydroxysuccinimide- PEG4- 
1, 2 Distearoyl-sn-glycero-3-
Phosphoethanolimine (NHS-
PEG4-DSPE) 
 
tethering 
moiety/lipid film 
anchor 
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Chapter 2: Sphingomyelin/ 1, 2-Dioleoyl-sn-glycero-3-phosphocholine/ 
Cholesterol Formulation and variants 
 I. Introduction 
 This chapter focuses on the development and optimization of the synthetic lipid analogue 
environment built for control and reproducibility.  This work focuses on a widely used and 
studied SM/DOPC/Cholesterol system, which has been used as a mimic for the lipid 
environment of a brain cell. It is shown here that synthetic lipid membranes are producible across 
a wide variety of components and molecules.  These lipid formulations can be used as 
representative analogues of all possible cell and organelle membranes to further increase the 
biological relevancy of these lipid microenvironments.  It is shown here that reproducible 
membranes with visibly quantifiable characteristics can be formed through a straightforward 
process of dissolution, mixing and drying to form starting materials for supported lipid bilayers 
on particles or surfaces. 
 II. Materials and Methods 
 Purified Sphingomyelin (SM), DOPC, cholesterol, Brain polar lipid extract (BPLE), 1,2-
Distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC), and L-α-phosphocoline (LPC) were purchased from Avanti Polar lipids in powdered 
form.  Fluorescent lipophilic tracers DiO, DiI, and Perylene were purchased from Molecular 
Probes, and added at 0.2%, 0.2%, and 0.4% (molar or weight equivalence as shown in Table 2.1) 
respectively in the lipid films in which they were used.  Chloroform 99.9%, extra dry was 
purchased from Fischer-Scientific.  
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 Lipid films were created by dissolving the purified lipids and lipophilic tracers in 
chloroform and then combining them to a total weight of 4 mg of total lipid and desired 
concentrations within 4 ml amber glass vials.  These mixtures, shown below in table 2.1 were 
then dried in a vacuum chamber overnight (minimum of 8 hours) protected from light to help 
preserve the fluorescence of the lipophilic tracers.  This process removes the chloroform from 
the mixture while leaving a deposition of the lipids in the glass vial, thus a film.  After drying, 
any unused stock solutions or films to be stored were placed in a positive pressure chamber and 
flushed with inert gas, sealed tightly in parafilm, and placed in desiccated jars in the freezer at -
20°C.  Any films prepared for immediate use were removed from the vacuum chamber and 
rehydrated with 2 mL of PBS. 
 The films, upon rehydration, were mixed vigorously using hand mixing and a vortex 
mixer to ensure that all deposited lipid was suspended into the PBS aqueous phase.  The 
rehydrated multilamellar vesicle (MLV) solution was then transferred from the amber glass vial 
into a 15 mL conical tube and placed into a 37°C water bath.  Allowing approximately 5 minutes 
for temperature equilibration, the MLV solution was then sonicated for 15 minutes in a 
BioLogics Inc. 150 V/T Ultrasonic Homogenizer.  This sonication produces a solution of small 
unilamellar vesicles (SUV) liposomes of relatively uniform size.  After sonication, the liposomal 
solution is placed in an Emerson centrifuge and spun at 1500 rpm for 2 minutes to remove any 
debris accumulated throughout the previous steps.  The supernatant is then transferred to a fresh 
15 mL conical tube.  500µL of the liposomal solution is taken from the newly centrifuged tube 
and placed in a 1.5 ml microcentrifuge tube.  This microcentrifuge tube is then replaced back 
into the 37°C water bath to once again equilibrate, approximately 5 minutes. These liposomes are 
then used further for varying liposomal fusion studies. 
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 Separately to the formation of lipid films and SUV solutions, glass surfaces and 5 um 
silica beads were prepped for lipid fusion.  Glass slides, coverslips, and silicon dioxide chips 
were cleaned overnight in Piranha solution, the supports were then washed thoroughly with DI 
water.  Piranha solution was made as a mixture of Sulfuric acid and Nochromix, (Fischer 
Scientific) at a ratio of 1 g of Nochromix for every 100 mL of sulfuric acid. To ensure the glass 
surfaces were free of piranha solution and any excess sulfuric acid, the washing was performed 
by submerging the glass support in pure DI water in an ultrasonic cleaning bath (Branson B1510 
Ultrasonic Cleaner) for 15 minutes, followed by a series of dunk washes in fresh DI water, and 
finally dried using compressed inert gas.  The 5 um silica beads (Bangs) were weighed out and 
mixed to a total concentration of 1 mg of beads per 1 mL of PBS in a 15 mL conical tube. This 
mixture was then placed in a bath sonication unit (Branson) for a minimum of 15 minutes, to 
break apart any microbeads that may have stuck together upon shipping and dry storage.  After 
sonication, an aliquot of the microbead solution was then placed into a 1.5 mL microcentrifuge 
tube and placed in the 37°C water bath until fusion. 
 After the SUV solution, the microbead, and glass surfaces have been prepped, then the 
liposomal solution is fused to the solid support structures.  To undergo fusion of the SUVs to the 
microbeads, 200 µL of the heated microbead suspension is pipetted dropwise into the 500 µL of 
SUV liposome solution.  After dropwise addition, the new mixture is lightly hand shaken, briefly 
mixed on the vortex mixer, and then placed in an end-over-end rotomixer located within a 
repurposed cell incubation chamber held at a constant 37°C.  This fusion was completed at 3 
separate timed intervals, 30 minutes, 18 hours, and 24 hours.  After these times have been met, 
the fused lipobeads solutions were spun down in a microcentrifuge, the unfused liposomal 
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supernatant was removed and replaced with fresh PBS, and then the pellet was then resuspended, 
this process was repeated 3 times. 
  To fuse the liposomal solution onto the planar glass surfaces, the heated liposomal 
solution was pipetted onto the clean glass and then placed into the above mentioned incubation 
chamber for 30 minutes.  The glass surfaces were then removed from the chamber and washed.  
There were three approaches to washing due to the intricacy and care needed to not shear off any 
of the fused lipid bilayer from the bare glass surface.  The first approach was a series of 
immersion in a petri dish filled with fresh PBS, after the immersion, the glass surface was gently 
removed from the petri dish, the contents of the dish were discarded and the surface was 
immersed again, repeated for a total of 3 washes.  The second approach was to pipette off the any 
excess liquid, leaving enough to just cover the extents of the fused area, then looping a small 
piece of parafilm around the opening of the pipette and adding fresh PBS back onto the surface.  
The parafilm was used to limit the shear force of the PBS leaving the pipette tip and dampen it 
over a broader area to minimize any bilayer disruption. This process was once again repeated 
thrice. The final technique was to remove any excess liposomal solution, similar to the second 
technique, however in the samples prepared with this technique the sample area to be imaged or 
tested was demarcated on the glass surface, so the fresh PBS was pipetted outside of this 
demarcated and the natural spreading and surface tension of the PBS was used to wet the surface.   
This process was performed 3 times, like all other samples, to insure them removal of any excess 
unfused SUVs from the final sample.  
 These samples were then imaged using both CLSM and AFM modalities.  The confocal 
images were obtained by excitation of the DiO and DiI probes with a 488nm laser, this laser 
would excite the DiO molecule which would then undergo FRET with the DiI probe, which 
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would then emit light between 550-600 nm collected by the detector, any light emitted by the 
DiO probe was collected between 500-549 nm.  CLSM imaging was also coupled with 2 super 
resolution techniques, the first being STimulated Emission Depletion (STED) from Leica and the 
second being Airyscan from Zeiss.  STED microscopy was performed for the DiI and DiO 
samples using an excitation beam of 488 nm, and a depletion laser of 592 and 660 nm in varying 
tests.  The Airyscan images were obtained using a 488 nm excitation beam and the same 2 
detection windows as stated in the base CLSM studies. 
 III. Results and Discussion 
 Throughout these tests a main staple of the experimental set up was the use of the DiO, 
donor, and DiI, acceptor, FRET method described in Baird et.al[88]. This method is a very 
powerful way to isolate out and quantify the apparent phase partitioning within our lipid systems.  
DiO and DiI do not fluoresce in solution, so there was no worry of any background excitation, 
and so the only source of emitted light would be from a lipid bilayer, on top of this fact the 
FRET technique yielded a secondary level of clarification and further delineation of the two 
phases believed to be present in these samples.  Figure 2.1 shows the comparison between 
samples containing no tracer, acceptor only (DiI), donor only (DiO), and with both dyes present.  
It is visible that under acceptor only conditions, the DiI signal is weakly visible throughout the 
lipobeads while illuminated at 488 nm.  In the donor only condition, the DiO signal is visible 
throughout the entire lipobead and shows a small, negligible amount of bleed through into the 
higher wavelength detection channel. However it is seen when the samples contain both DiO 
donor and DiI acceptor the lipobead yields bright signal in both channels, and in this case the 
DiO signal is slightly weaker than in the donor only case due to the FRET phenomenon. These 
two lipophilic probes have been shown to have an innate preference of one lipid phase over 
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another, this was a point of contention once or twice throughout all of these studies, and this 
preference is a tendency to partition into the Ld phase of the bilayer.   
 
Figure 2.1 FRET dye pair validation. This chart shows the use of the FRET fluorophore labeling 
structure.  All lipobeads were illuminated with a 488nm laser and the detected emission windows are 
shown on the left.  All of the lipobeads images have their intensities normalized. In samples containing 
neither the DiI nor the DiO probe, no emitted light is seen in either window.  In samples containing 
strictly the DiI fluorophore, the fluorophore is shown to emit a very low and weak signal barely above the 
overall noise level of the samples.  The samples containing only the DiO lipid show a very bright 
emission in the expected DiO detection range with a small amount of bleed through into the DiI detection 
window.  Finally, samples containing both the DiI and DiO lipid show bright signal in both detection 
windows, however the signal seen in the DiO detection window is slightly dimmer than in the samples 
containing only DiO, this is due to the FRET phenomenon in which a large number of DiO molecules will 
not emit excess energy as light but transfer it to the DiI fluorophore. 
 Initial tests were performed on two systems to verify the existence of visual phase 
separation.  Previous work had shown a system containing BPLE, LPC, and Cholesterol would 
yield a confluent lipid membrane for use in lipobeads systems, and maintained activity of key 
TMPs, most importantly γ-secretase.  However, one drawbacks of this lipid system was the 
inability to discern lipid phases and thus lacked important spatial and microenvironmental 
information which was a desired trait, of the γ-secretase system, to study.  BPLE is a desirable 
component for use in a synthetic mimic of a brain cell microenvironment due to the fact that it is 
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a total extract of lipid material from lysed brain cells, which affords any brain cell TMPs a more 
biologically relevant microenvironment.   
Figure 2.2 shows the comparison of lipobeads of the SM:DOPC:cholesterol 
formulations(2.2 A, B) to those composed of the BPLE:LPC:cholesterol (2.2 B, C) lipid 
formulation.  The fluorescent spectral scans in panels B and D shows that both of the lipid 
formulations contain the DiO donor and DiI acceptor pair of fluorophores, with emission maxim 
of 505 nm and 555 nm respectively. Panel B shows the comparative intensities calculated from 
the two highlighted inset regions, a readout of the FRET spectral signature of the Lo and Ld 
phases. The intensities of the dyes are approximately 4-fold higher in the Ld phase, and the 
relative intensity of the donor to acceptor decreases in the less concentrated Lo phase, indicative 
of a change in FRET efficiency. 
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Figure 2.2 Spectral comparison of simplified analogue versus biological membrane.  A) Synthetic 
SM:DOPC membranes shown here with visual phase separation were spectrally imaged, the insets show 
the equatorial z section lambda scan from isolated beads from the indicated ROIs to elucidate the intensity 
difference in emission intensities between the Lo and Ld phases. Panel B shows the comparative 
intensities calculated from the two highlighted inset regions a readout of the FRET spectral signature of 
the Lo and Ld phases. Panel C shows A BPLE:LPC lipid bilayer formulation here shows no visible signs 
of phase separation and shows high levels of FRET intensity. Panel D displays graph showing the 
spectrum obtained from the BPLE:LPC lipid formulation as well as a comparative spectrum from a 
SM:DOPC lipid formulation which contained only the acceptor (DiI) fluorophore of the FRET pair. 
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The BPLE containing lipobeads in figure 2.2 C have a distinct lack of any visual phase 
separation at this resolution.  Panel D displays a graph showing the spectrum obtained from the 
BPLE:LPC lipid formulation as well as comparative spectrum from a SM:DOPC lipid control 
formulation which contained only the acceptor (DiI) fluorophore of the FRET pair. It is believed 
that phase separation within this system does in fact occur, but that it occurs on a nanoscale 
length scale as opposed to the micron scale seen in the SM/DOPC lipid membrane system.  This 
nanoscale phase separation is well below the resolution limits of light microscopy, even when 
factoring newly developed super resolution techniques such as STED and Airyscan.  It is also 
believed that due to the multitude of varying lipid species in the BPLE membrane, that these 
rafts not only are nano-scale but may also be highly transient as it has been shown in previous 
work that rafts tend occur along critical points and energetic tie lines within the ternary lipid 
phase diagrams.  This lack of visual phase separation led to the adoption and prominent use of 
the SM:DOPC:cholesterol, or 2/2/1, lipid membrane formulation throughout most of the studies 
performed.  
A contention over this partitioning arose when reading Feigenson et al.[27], [104] which 
described that in synthetic, biomimetic membranes both DiO and DiI partition into the Ld phase 
in SM:DOPC:cholesterol, which is the precise system in which the work here is completed.  The 
Baird et al. paper describes that the DiO and DiI probes are found more commonly in the 
detergent resistant, or Lo, phases of cell membranes, since there work was performed in cell 
cultures expressing both the DiO and DiI probes.  This discrepancy between the two formats and 
difference in synthetic versus biological was debated vigorously, but upon further study of our 
systems, the DiO and DiI emission showed many more characteristics of presenting in the Ld 
phase, similar to the work of Feigenson.   
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This preference is a key aspect as to why we chose a 2 probe FRET approach.  As stated, 
this partitioning of the fluorescent probes is a preference, but it does not eliminate the presence 
of the fluorescent probe in the opposite phase, thus making it more difficult to clearly see the 
delineation between Lo and Ld phases in the bilayer.  With the 2 probe approach, the FRET 
readout of the probes means that the donor and acceptor dyes are distributed in the bilayer 
together, as this FRET phenomenon only occurs when two probes are approximately between 3-
6 nm apart and is thus proportional to the concentration and therefore the partitioning of the 
probes between Lo and Ld phases.   This phenomenon limits the amount of signal seen in areas 
that are sparsely populated by both fluorophores, and occurs only when a sufficient concentration 
exist within the membrane.  If both probes have a preference to the Ld phase, and only under 
FRET when in close proximity, it is understandable the fluorescence we collect from the 
acceptor DiI probe would happen almost exclusively in the Ld phase of the lipid bilayer.  While it 
is possible to isolate the fluorescent signal of the disordered phase, it leaves the ordered phase to 
be imaged by the examination of the lower registers of the detected fluorescence, utilizing the 16 
bit depth of the modern confocal microscopes (0-65536 levels for 16 bit versus 0-256 levels for 8 
bit detection).  This would mean that what is seen in the data collected, is that the areas devoid of 
fluorescence on the planar surface or microbead constructs is the Lo phase (shown as false red 
color in Figure 2.2 A). 
Upon further study of this fluorescent dye system a secondary approach was attempted to 
verify the existence of a confluent lipid bilayer, while maintaining the ability to discern visual 
phase separation.  A third fluorescent probe was added into the lipid film formulation, Perylene.   
From Feigenson’s work with fluorophores in lipid systems and its use in the Dimova paper, 
which heavily influenced the work performed, it was deemed a viable candidate to help elucidate 
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the confluency of the lipid membranes within the lipobeads systems[27], [104].  However Figure 
2.3 shows that upon inclusion of this tracer the bilayers lost their visible phase separation 
throughout multiple different lipid membrane formulations which had repeated yielded 
quantifiable phase separation. Also visible in this figure is the presence of unfused liposomes 
containing what appears to be exclusively Perylene signal.  The Feigenson and Dimova work 
was predominantly performed in giant unilamellar vesicle (GUV) systems, which have vastly 
different formation methods than the lipobeads of planar supported bilayer systems in this work.  
This difference could be the reason of the discrepancy between their work and the work 
performed here, as the fusion process of our planar surfaces and microbead systems is the main 
aspect believed to be causing this difference, and this step does not occur in GUV tests.   
The fusion step in the samples presented, can cause non-homogeneity to occur within our 
samples, a problem that will be addressed later in this work.   This lack of homogeneity arises 
from the randomness of the fusion process and sonication process within these tests.  During the 
probe sonication process to produce SUVs which are then used in the fusion step, these SUVs 
are created through a series of rapid expansion and compression causing the cavitation and 
reformation of larger MLVs into the SUVs used.  This cavitation and reformation process is done 
through no external control, outside of forcing cavitation, and thus is a pseudo-self-assembly 
process which is dictated ultimately by energetics of the system.  It makes sense in this case that 
if given the size discrepancy and saturation differences of both the DOPC and SM lipids that 
reformation would be favorable for vesicles comprised of the same lipids, yielding a potential 
range of liposomes from only DOPC to only SM and the gamut in between. Furthermore, we 
expect mechanical differences where the more Lo-like liposomes are more rigid and thus would 
fuse at lower rates during lipobead formation.  This heterogeneity in liposomes for fusion can 
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lead to a slight disparity in fusion times required by different liposomes in order to fully coat the 
solid support structures.  The addition of Perylene into these systems could exacerbate this 
heterogeneity leading to an overall increase in the predominance of a single phase, Ld, microbead 
fusion. This heterogeneity is likely the cause of the unfused liposome seen in figure 2.3.  The 
addition of Perylene was eliminated from further studies. 
 
Figure 2.3 Overlay of Perylene and DiI detection in SM:DOPC:cholesterol formulations. A) 
Perylene signal obtained by illuminating the sample with a 405 nm wavelength light and detecting at 450-
480 nm, B) DiI signal obtained by illuminating with 488 nm wavelength laser and detecting at 550-600 
nm range. C) Composite overlay of the two showing no apparent phase partition.  However, in the 
Perylene and composite images small unfused liposomes can be seen attached to the lipobeads and free 
floating in the sample.  These free liposomes do not show any visible DiI signal, suggesting that they are 
predominantly Lo phase liposomes. 
The question of confluency is however addressed by the presence of low levels of the 
DiO lipid tracer throughout the microbead system.  As stated before, the DiO and DiI lipophilic 
tracers do not fluoresce in solution, and in all of the solid supported systems, excess and unfused 
liposomes other material is washed out from the system over the course of three washes.  While 
analyzing the microbeads, the ability of the lipophilic tracers to partition into both phases of the 
lipid bilayer became a benefit.  By increasing the low end intensity of the DiO signal, it becomes 
apparent that this signal can be seen surrounding the entirety of the microsphere.  This low signal 
is above the noise levels inherent in CLSM detectors, and thus signifies the confluency of the 
bilayer spanning the entire microbead.  This can be checked across all samples, and thus can be 
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used to insure proper fusion of the SUV solution onto the solid support systems.  Figures 2.4, 
2.5, and 2.6 show examples of this analysis across 2 tested samples.  Figure 2.4 shows a 2 phase 
system in which the phases have each coalesced into separate domains, the average intensity 
over the line shows 2 distinct regions in terms of intensity, which are both above background 
levels.  The region with high intensity is the Ld phase, while the low intensity region is the Lo 
phase of the lipid bilayer.  Figure 2.5 shows a CLSM image with a similar intensity chart as the 
previous figure, however due to the interdigitating of the phase separation regions and the lack of 
sub 200 micron resolution, it is difficult to distinctly make out the phase regions, however a 
similar trend to what is seen in the previous figure is observable.  To further ratify this claim, 
figure 2.6 shows an Airyscan image of the same lipobeads observed in figure 2.5, with much 
higher resolution and the ability to distinctly observe the intensity difference between the two 
phase regions. 
 
Figure 2.4 CLSM general intensity over a domain ripened lipobead. As shown, a DiO fluorophore 
intensity was obtained for the bisecting line through a hemispherical projection of a domain ripened 
lipobead.  The intensity can be seen to have roughly 2 intensity regimes which correspond to the Ld phase 
shown as the higher intensity or top portion of the lipobead, and a less intense Lo phase shown as the 
bottom portion of the lipobead. 
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Figure 2.5 CLSM general intensity over a representative bead.  Shown here is the DiO fluorophore 
intensity obtained along the line bisecting the hemispherical projection of a single representative bead.  
The intensity levels fluctuate over the entirety of the bead and due to resolution limitations it is difficult to 
isolate an average intensity value for the Lo or Ld phase. 
 
Figure 2.6 Airyscan general intensity over a representative bead. This figure shows the associated 
Airyscan image of the representative bead in figure 2.5.  With the resolution increase provided by the 
Airyscan modality it is possible to view the relative intensity level differences between the Lo and Ld 
phases. 
Proceeding the confirmation of the confluent lipid bilayer the next hurdle necessary to 
overcome was the aforementioned discrepancy with homogeneity.  A key concept of the 
supported bilayer approach is the repeatability and normalization of test platforms for potential 
use in high-throughput systems. Lipobeads ranging from total Lo coverage to total Ld coverage 
have the ability to confound samples specifically tailored to test the effects of lipid 
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microenvironment on protein function.  In order to test this homogeneity in the samples, 3D z-
stacks were taken using CLSM, and processed in ImageJ software by making hemispherical 
projects of the top and bottom hemispheres of the microbeads.  These projections were 
thresholded to isolate the bright Ld phase areas, and then overlaid with a mask to normalize for 
the loss of geometrical data, when the images was reduces from 3D to 2D in the hemispherical 
projections. The thresholded images was then ratioed with the mask to produce a coverage 
percentage, signifying the percentage of the hemisphere covered by the Ld phase.  Initial tests 
were performed by allowing the SUV solution to fuse with the silica microbeads for a maximum 
of 30 minutes, but following analysis of these samples, the Ld coverage obtained from these 
samples averaged out to approximately 77%± 23% showing a distinct preference for Ld phase 
coverage.  The standard error shows that the overall variance in lipid phase distribution is very 
high, yielding a wide range of lipid microenvironments which is not ideal for a potential high-
throughput modality with control of lipid microenvironment.  One suggested approach on 
refining this variance was to employ the use of flow cytometry, which had been shown as a valid 
method to isolate desirable test sets from a varied population of lipobeads.  However, since the 
average coverage was well above the desired and predicted 50/50 split, garnered from the fact 
that there are equal parts SM and DOPC in the lipid formulation, and the prediction from the 
phase diagram presented in Dimova et.als. work, it was suggested to extend fusion times before 
continuing to cytometry. 
As mentioned above, the discrepancy of fusion and heterogeneity problem was the 
potential cause of this high Ld phase fusion.  It was proposed that extending fusion time to long 
times could afford the solutions a better chance to reach an equilibrium and allow for more rigid, 
largely SM/cholesterol based liposomes, more time to undergo deformation and fusion with the 
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microbead systems.  A fusion time of approximately 18 hours, overnight fusion, at 37°C was 
tested, and upon analysis of the microbeads, the Ld phase coverage reduced from the 77% above, 
to a value of 55% ± 19%, much closer to the desired ~55% from the phase diagram shown in 
figure 2.7, this difference can be seen on the lipobead constructs in figure 2.8.  Figure 2.9 shows 
a histogram of the 2 samples, the short fusion time samples in blue, and the long fusion samples 
in red. In this figure it can be seen that overall median coverage has shifted down closer to the 
projected 55/45 Ld/Lo split, and an overall decreased spread in overall coverages.  To further 
understand the effects a long fusion time had on the characteristics of the fused lipid bilayer, 
Fluorescence Recovery after Photobleaching (FRAP) analysis was performed on both samples in 
the Ld phase.  Both of the fusion samples were observed to have a strikingly similar effective 
diffusivity of approximately 0.103 ± 0.04 µm2/second for the short fusion lipobeads (n=7), and 
approximately 0.104 ± 0.03 µm2/second for the long fusion lipobeads (n=15). The mobile 
fraction of the short fusion sample was calculated to be 94 ± 4%, while the mobile fraction of the 
long fusion was calculated to be 88±9%.  Both of the values, diffusion and mobile fraction, are 
not found to be statistically significantly different.  This shows, as expected, an extended fusion 
time does not negatively impact the diffusive characteristics of the membrane. 
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Figure 2.7 Ternary Phase Diagram of the Sphingomyelin:DOPC:Cholesterol lipid formulation.  
This is the expected regime in which the SM:DOPC:Chol liposomes will be formed, as well as the 
distribution of phases found on the microbead system.  It is shown (blue star) that the 40:40:20% 
formulation of these molecules should yield an even distribution of both Lo and Ld phases on the 
microbeads. 
 
Figure 2.8 Comparative phase separation of short and long fusion times on the 
SM:DOPC:cholesterol lipid formulation. This image shows the comparison of the lipobeads fusion step 
performed at 30 minute and 18 hour intervals.  These are top and bottom hemispherical projections of the 
3D images obtained from the LSM800 Zeiss microscope. The phase separation is visible in both 
examples, however the 18 hour fusion sample shows a more consistent phase separation from PLB to 
PLB. 
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Figure 2.9 Histogram of coverage analysis.  A histogram showing the overall liquid disordered phase 
coverage values of the 18 hour fusion (red) and 30 minute fusion (blue).  The blue histogram shows a 
population with an average value of 77% ± 23% total Ld phase coverage, while the blue histogram shows 
a population with an average Ld coverage of 55% ± 19%. Shown is the normalizing effect a prolonged 
fusion step had on the samples overall yielding a tighter distribution of lipobeads as well as one centered 
more closely to 50% coverage, the expected value from the ternary phase diagram 
Due to the high randomness and interdigitating of the visible phase separation in the 
SM:DOPC:cholesterol samples, they were a prime candidate to analyze and test out the 
aforementioned super resolution technologies available, STED and Airyscan.  The Leica STED 
was the first available option to use for this study.  However, as seen in figure 2.10, STED did 
not yield any increase in resolution in any of the x, y, or z imaged planes.  Upon further research 
into the STED functionality, due to its use a depletion laser, the fluorescent dyes used in imaging 
must be optimized for emission depletion by the available lasers.  The depletion lasers available 
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were a 592 nm, 660 nm, and 775 nm laser.  All three were used to test both the DiO and DiI 
probes, but none of them showed any increased resolution, even after deconvolution. 
 
Figure 2.10 Comparison of STED super resolution to CLSM imaging of DiI fluorophore. Shown 
here is a comparison between A) base confocal microscopy using a Leica SP8 microscope, and B) a 
STED confocal image from the same microscope set up.  These images show no visible signs of any 
resolution increase from using the DiO/DiO fluorophore lipid tracers as the fluorophore of interest. 
The Zeiss Airyscan was the made available shortly after the STED, and its use of a 
detector and pinhole array did not require specific fluorophores nor for them to be optimized.  
The Airyscan method is more of a mathematical reconstruction method, as opposed to the STED 
direct measurement.  As seen in figure 2.11, the difference between Airyscan and base CLSM is 
a significant increase in resolution. In the highlighted area it can be seen that under base CLSM 
imaging, the dark area (Lo phase) is comprised of a combination of both Lo and Ld phases, just at 
the resolution limitation of CLSM this area is predominantly Lo and is visually represented as 
such.  This increase in resolution using the Airyscan technology allows for the refinement of the 
coverage analysis to more adequately represent and understand the complexities of phase 
separation and in further studies, allow a better quantification of phase and spatial preferences of 
reconstituted TMPs. 
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Figure 2.11 Comparison of Airyscan super resolution imaging versus CLSM of DiI fluorophore. 
This is a comparison of the A) Airyscan imaging technique used on the Zeiss LSM800 to B) confocal 
image obtained under the same conditions.  The zoomed region highlighting one bead shows further 
conclusive evidence that there is a significant resolution increase between the two modalities allowing for 
the further elucidation and clarification of lipid phase separation.  In these images the green color is the 
emission from the DiI FRET acceptor lipophilic probe while the system is illuminated by a 488nm laser. 
Throughout these SM:DOPC:cholesterol studies, one main drawback of the system was 
considered:  the effective biological relevancy of such a basic ternary lipid formulation.  It was 
necessary to understand what happens when shifting from the BPLE lipid formulation seen 
above, to the ternary SM:DOPC lipid formulation.  This was tested by creating a series of 
SM:DOPC lipid formulations with increasing concentrations of BPLE doped into the 
formulation.  The system was doped from 0-75% BPLE, specifically 0%, 25%, 50%, and 75% to 
determine the effects of increasing the concentration of a more biologically relevant lipid species 
would have on the visible phase separation, and later the diffusivity of the lipid bilayer.  Figure 
2.12 shows the steadily increased dopant concentrations, and it can be seen that when the lipid 
begins to shift into a BPLE dominant membrane, starting at 50% doping, the fused lipids become 
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unstable on their microspherical solid supports and begin to slough off the microbead and “melt” 
onto the coverslip.  However, in the samples containing 25% and less BPLE, visible phase 
separation is still achieved to a quantifiable degree similarly to the pure SM:DOPC lipid 
formulations tested above, indicating that these BPLE systems will provide a new framework to 
study membrane protein partitioning in more natural and brain-like lipid microenvironments.  
Figure 2.12 Varying BPLE dopant concentration into canonical SM:DOPC:cholesterol formulation. 
This figure shows the comparison of varying levels of BPLE lipid mixtures on the structural integrity and 
phase separation visibility on normal SM/DOPC/cholesterol levels. Panel A is the 25% BPLE dopant 
mixture, Panel B is the 50% dopant mixture, and Panel C shows the 75% dopant.  (Displayed using Amira 
5.43 using the Volren technique.) At each tested concentration, visible phase separation is present on the 
lipobeads constructs, however at concentrations of 50% and above the lipid formulation becomes unstable 
in its fusion to the silica microsphere surface and begins to effectively slough off of the surface of the 
lipobead and mobile lipids move onto the glass coverslip surface. 
Upon doping the SM:DOPC system with lipids extracted from living brain cells, it was 
also suggested to look into other possible dopants to increase the diversity of the lipid 
environment on the solid supports, while also allowing for the lipid system to more accurately 
mimic a biologically relevant system, all while maintaining low levels of complexity and high 
repeatability.  The second dopants chosen where two fully saturated straight chain lipids, DSPC 
and DPPC.  Research has shown that when a cell develops cancer, the lipidomics of the 
membranes shift wildly from the native healthy cell configurations, and in specific cases such as 
A 
C 
B 
37 
 
prostate cancer, the amount of saturated lipids, such as DPPC and DSPC, within membranes 
increased[105]. To mimic this effect in lipobead systems, we used the SM:DOPC:cholesterol 
platform to investigate these changes.  Figure 2.13 shows three separate samples containing low 
levels of these DSPC and DPPC lipids doped into the membrane.  Panels A-C compare the 
effects of increasing addition of the long saturated straight chain DPPC and DSPC lipid into the 
SM:DOPC:cholesterol base mixture. Panel A is a 0.5% doping of the saturated lipids, panel B 
results from doubling the concentration to 1% doping, and panel C results from a 5% doping of 
the saturated lipids.  Substantial nanoscale phase separation is visible in both the 0.5% and 1% 
doping level images but is no longer visible in the 5% doped sample.  However, at a level of 5% 
DPPC and DSPC it is shown that these lipobeads undergo a phenomenon known as domain 
ripening, in which the phases coalesce and separate as much as possible leaving 2 large single 
phase structures as opposed to continuously interdigitated nano- to microscale phase separation 
we have seen in all of the other lipobead samples of the SM:DOPC:cholesterol formulation.  If 
this process occurs in cancer cells, it would provide a mechanism for strongly perturbing cell 
signaling that could drastically affect malignant cell function and membrane protein partitioning 
and dynamics.  
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Figure 2.13 Variation of Saturated lipid dopant into canonical SM:DOPC:cholesterol (2:2:1) lipid 
formulation.  Panels A-C compare the effects of increasing additions of the long straight chain DPPC 
and DSPC lipid into the SM/DOPC/cholesterol base mixture. Panel A is 0.5% doping of the saturated 
lipids, panel B results from doubling the concentration to 1% doping, and panel C results from 5% doping 
of the saturated lipids.  Substantial nanoscale phase separation is visible in both the 0.5% and 1% doping 
level images but it is no longer visible in the 5%, doped sample.  However at a level of 5% DPPC and 
DSPC it is shown that these lipobeads undergo a phenomenon known as domain ripening, in which the 
phases coalesce and separate as much as possible leaving 2 large single phase structures as opposed to the 
continuously interdigitated nano- to microscale phase separation seen in all of the other samples of the 
2:2:1 lipid formulation.  
Throughout these experiments, FRAP was also performed on a large number of these 
platforms.  These FRAP experiments provide two key parameters of lipid bilayer fluidity and 
diffusivity.  These parameters being the mobile fraction and the effective diffusivity of the 
photobleached area.  In these samples it is expressed as “effective diffusivity” due to the 
existence of phase separation within the system, and the evidence suggested in the Airyscan 
images, which is that these phases exist below the resolution limitation of the CLSM, and in 
further studies is shown to propagate even below the resolution limitations of super resolution 
into the nanoscale regime. Figure 2.14 shows a representative FRAP analysis following the 
method in Klonis et al.[106].  The results were obtained by photobleaching 1 µm2 areas along 
the equatorial region of the lipobeads.  Using this cross section of the lipobeads afforded the 
ability to analyze multiple instances of FRAP across a single lipobeads, with enough distance 
between the bleached areas to avoid any over bleaching or cross talk between the analyzed areas. 
The representative FRAP profile in figure 2.14 was developed from a sample fused for 18 hours. 
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The x-axis is time in seconds and y-axis is overall normalized recovery. FRAP was performed on 
both the visually discreet Ld and Lo phases. The Lo phase shown in here in orange, has low 
effective diffusivity at approximately 0.001 µm2/s, ~2 orders of magnitude different to the Ld 
phase shown here in black with an effective diffusivity of 0.106 µm2/s.     
Figure 2.14 FRAP analysis performed on SM:DOPC:cholesterol formulation. A representative 
FRAP profile developed from a sample fused for 18 hours, the x-axis is time in seconds, and the y-axis is 
overall normalized recovery.  Frap was performed on both visually discreet Ld and Lo phases.  The Lo 
phase shown here in orange, has low effective diffusivity at approximately 0.001 µm2/s , a 2 orders of 
magnitude different to the Ld phase shown here with an effective diffusivity of 0.106 µm2/s 
IV. Conclusions 
The work described here shows significant strides in developing a stable, reproducible, 
and modular platform, on which effective high-throughput processes can be performed, ranging 
from microwell plating assays to flow cytometry.  The development of mobile and diffusive 
membranes is possible on an array of solid support structures, tested here was the spherical 
microbead surface, but the approaches used are rather ubiquitous in nature, and thus could be 
applied to various tailored supports including planar and tethered systems.  With the rise of 
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micromanipulation, 3D printing, lithography, and nanofabrication, there is very little limit to the 
potential applications of these lipid systems.  A major drive in this work however is to not only 
develop synthetic membrane systems, but to increase their biomimetic capabilities while 
maintaining key advantages of the synthetic systems. 
The highly reproducible, canonical SM:DOPC:chol lipid formulation used throughout 
years of lipid studies is shown to be a viable basis on which to build this modular biomimetic 
system.  It is a widely used baseline mimic in brain membrane studies, and is shown to be highly 
effective.  However, this is still just a ternary system compared to the tens of thousands of lipid 
components found in living cells. By taking this formulation and augmenting it slightly with a 
host of varying dopants, it is possible to develop vastly different and compelling 
microenvironments more similar to those in living cells, but maintaining Lo/Ld phase separation.  
These microenvironments are shown to have substantial effects on TMP function, specificity, 
and efficiency.  Through the development of more biologically relevant membranes, it is 
possible to close the gap between cell culture and low through-put experimental methods and 
highly reproducible, rugged, synthetic high- throughput modalities. 
 
 
 
 
 
 
41 
 
V. Tables  
Table 2.1 Additional Materials.  
Materials 
Name Atomic Structure Properties 
Perylene 
 
Lipophilic 
fluorescent tracer. 
Excitation/Emission: 
405/ 450 
 
Table 2.2 Lipid formulations. This table contains the overall lipid formulations used throughout the 
studies within this work.  Due to the fact that the BPLE lipid was a mixture of all lipids obtained from a 
lysed brain cell, it was necessary for the formulations to be weight based in their distribution as there was 
no equivalent molar weight  
Lipid Formulations 
  Sphingomyelin DOPC DPPC DSPC Cholesterol BPLE L-alpha-PC Basis 
2/2/1 40 40     20     Mol % 
BPLE/L-a-PC/chol         10 34 56 Wgt % 
BPLE doped 2/2/1 1 11.25 10.75     3 75   Wgt % 
BPLE doped 2/2/1 2 22.5 21.75     5.75 50   Wgt % 
BPLE doped 2/2/1 3 32.5 31.25     11.25 25   Wgt % 
BPLE doped 2/2/1 4 40 39.25     10.75 10   Wgt % 
Cancer lipidome test 1 40 30 5 5 20     Mol % 
Cancer lipidome test 2 40 38 1 1 20     Mol % 
Cancer lipidome test 3 40 39 0.5 0.5 20     Mol % 
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Chapter 3. Gamma Secretase and Substrates in Proteolipobeads 
 I. Introduction 
 The transmembrane proteins studied in this work comprised of γ-secretase and truncated 
versions of two of its known cleavage substrates, Amyloid Precursor Protein (as SB4) and 
Notch-1 (as NTM2).  These proteins have a significant impact on disruptive and deadly diseases 
and are thus prime candidates for study in the pharmaceutical industry as potential drug and 
therapy targets.  The work in this chapter was performed by using optimized 
SM/DOPC/cholesterol brain lipid analogues, to understand and elucidate key native protein 
characteristics such as diffusivity throughout the membrane, potential partitioning of the protein 
into one of the two lipid phases, and activity within these synthetic constructs.    
 II. Material and methods 
 γ-secretase, the Amyloid Precursor Protein (APP) based substrate SB4, and the Notch-1 
based substrate NTM2 were secured from the Li lab at Memorial Sloan Kettering Cancer Center.  
Proteins were obtained as extractions from genetically modified cell lines, which causes over 
expression of the proteins of interest[107], [108].  All samples were provided as surfactant 
stabilized extractions.  The surfactant used in these studies is CHAPSO. Table 3.1 shows the 
auxiliary molecules used in this section. 
 Lipobead solid support structures were developed using the aforementioned methods in 
the previous chapter.  These fused and washed samples were then incubated with the surfactant 
solubilized TMP extractions in a 0.25% mixture of CHAPSO for 1 hour at 37°C in the 
repurposed incubator, while constantly mixing in an end-over-end rotomixer.  γ-secretase was 
incubated at 0.07 ng/ml, SB4 at 60µM, and NTM2 at 100 nM, within their respective studies.  
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Following the incubation, the samples were then washed thrice, using the same procedure as 
above, and fresh PBS. 
 During the hour long incubation, a mixture of Steptavidin conjugated with Alexafluor 
660 (StAv-AF660) was prepared.  25 µl of a 1 mg/ml stock StAv-AF660 solution was diluted 
into 10 ml of fresh PBS in a 15 ml conical tube. The StAv-AF660 solution was then subjected to 
a Bio-Bead SM-2 Adsorbent (Bio-Rad) clean up regimen in order to remove any unfolded or 
damaged proteins ad fluorophores which may non-specifically bind to the protein or lipid 
components of the system.  After mixing and incubation with the Bio-Beads, the StAv-AF660 
solution was passed through a 0.2 micron filter, to remove the Bio-Beads and further eliminate 
any unusable complexes.  This final 2.5 µg/ml StAv-AF660 solution is further diluted to various 
concentrations throughout the experiments herein.  
 After the washing of the lipobeads systems following incubation with the associated 
protein solution, the proteolipobead systems containing APP and Notch-1 were then mixed and 
incubated with the StAv-AF660 fluorophore solution in order to label the proteins which have 
been reconstituted into the lipid bilayer.  The SB4 and NTM2 substrates obtained from the Li lab 
have an intrinsic biotinylation site developed in vivo, through genetic modification.  This 
exposed biotin molecule is used to bind the conjugated StAv-AF660 and thus label the protein 
within lipid bilayer in order to track it through CLSM. 
 Membrane fragments of HEK293 cells containing γ-secretase with the subunit nicastrin-
pHuji red fluorescent protein (RFP) variant as a C-terminal fusion protein cells were solubilized 
with 1% CHAPSO[109]. The solubilized membrane fragments were mixed with the DiO-doped 
2:2:1 DOPC/Sphingomyelin/Cholesterol liposomes followed by dilution to give less than 0.01% 
final CHAPSO concentration. Centrifugation was used to remove any aggregates to give a clear 
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solution of DIO-doped γ-secretase proteolipomes incorporating the subunit nicastrin-pHuji red 
fluorescent protein (RFP). These proteoliposomes were fused with 5 μm nominal size silica 
microspheres (Bangs Laboratories) for 30 min at a ratio of greater than 10:1 lipid bilayer area to 
total microsphere surface area, followed by four wash steps to remove excess proteoliposomes or 
any γ-secretase containing membrane fragments or other debris. 
 III. Results and Discussion 
 Initial tests were performed with γ-secretase substrates SB4 and NTM2, prior to 
experimenting with the larger multi subunit protein γ-secretase.  Figure 3.1 shows the overlaid 
images of the phase separated SM:DOPC:cholesterol lipid bilayer and the StAv-AF660 labeled 
proteins.  Using this approach it is relatively straightforward to see the colocalization of the 
substrates and the lipid phases.  In the samples analyzed within this work, the intensity ratio was 
evaluated with respect to the ordered phase.  We first form Lo/Ld phase separated lipobeads and 
then conduct direct membrane protein insertion, followed by localization with StAv-AF660 
(yellow). Then confocal fluorescence microscopy was conducted of substrates loaded into phase 
separated PLBs with Lo/Ld microdomain forming SM:DOPC:cholesterol (2:2:1) composition. 
Figure 3.1 shows the results of representative confocal laser scanning microscopy (CLSM) 3D 
reconstructions. Shown in panels 3.1 A-F are 3D hemispherical projections of a representative 
PLBs where the extent of the Ld phase is indicated by DiI (Acceptor) FRET (blue: Panels 3.1A 
and 3.1D). The biotinylated labelled substrates SB4 and NTM2 are localized with StAv-
AF660(yellow), excited by a 633 nm laser line to eliminate crosstalk, displayed in panels 3.1B 
and 3.1E respectively. The third column, panels 3.1C and 3.1F, were obtained by merging the 
first two columns. We obtained the apparent partition coefficient of the protein (Kp,app) by closer 
examination of signal intensities of the Lo/Ld phase partitioning in a random sampling of PLBs of 
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each kind (n=10). Using this data, the SB4 substrate partition coefficient Kp,app is 0.55±0.03, 
indicating strong preferential partitioning to the DOPC-rich Ld phase (based on 
SB4:StreptavidinAlexaFluor660 phase partitioning). In contrast, the non-amyloidgenic Notch 
NTM2 substrate shown in the panel  shows major loading into both the Ld and Lo phases, Notch 
NTM2 substrate partition coefficient Kp,app is 1.03±0.08, indicating only slight preferential 
partitioning to the DOPC-rich Ld phase (based on Notch-NTM2:StreptavidinAlexaFluor660 
phase partitioning). For reference, a Kp,app value of 1 indicates no preference for either phase. 
The differences between Lo/Ld Kp,app were statistically significant in each sample (p < 0.05). 
After analyzing this data, it shows that the NTM2 substrate has no distinct preference for 
partitioning into either phase of the lipid bilayer while the SB4 substrate shows a minor yet 
significant preference for the Ld phase.  This preference of the studies of an APP-based substrate 
is similar to that seen in previous GUV studies performed by Schlebach et al.[110]   
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Figure 3.1 Colocalization of TMPs and Ld phase highlighted lipid membrane. A&D) Phase separated 
SM:DOPC lipid bilayers shown here fused to a microbead. B&E) SB4 and NTM2 substrates shown here 
are reconstituted into the lipid bilayer and then fluorescently labeled with a StAv-AF660 molecule to bind 
to any exposed/outward facing biotin site. C&F) a merge of the 2 channels to show colocalization of SB4 
in the Ld phase, and no apparent partitioning preference for the NTM2 molecule. 
During the implementation of γ-secretase supported biomembrane systems, the Li lab developed 
a new modified version of the γ-secretase complex which is expressed containing a pH 
dependent red fluorescent protein (RFP).  Specifically, the enzyme complex contains Nicastrin-
pHuji red fluorescent protein (RFP) variant as a C-terminal fusion protein. These constructs were 
developed in a cell modified to show significant upregulation and over expression of γ-secretase.  
A benefit of RFP is that it is a highly optimized fluorophore for use in the STED super resolution 
modality.  Figure 3.2 displays STED and CLSM microscopy of a representative HEK293 cell 
over expressing γ-secretase labeled with RFP (as pHuji).  The 3D reconstruction displays a 
representative HEK293 cell that contains overexpressed γ-secretase visualized due to 
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incorporation of the subunit nicastrin-pHuji red fluorescent protein (RFP) variant as a C-terminal 
fusion protein.   Optical sectioning of the 3D cell was used to isolate the plasma membrane 
localization of γ-secretase, shown in the insets. A comparison of the same z section in CLSM and 
STED shows the significant resolution increase obtained. The diffusivity of the γ-secretase 
protein in the plasma membrane was obtained through FRAP and determined to be 0.025 
µm2/sec (as shown in figure 3.3) with a mobile fraction of ~79%.  To our knowledge, these 
studies constitute the first diffusivity measurements of γ-secretase. The γ-secretase from these 
cells was then extracted from membrane fragments in 1% CHAPSO and proteoliposomes were 
formed.  The 2:2:1 DOPC/Sphingomyelin/Cholesterol lipid formulation doped with DiO tracer 
was used to form proteoliposomes. PLBs were formed via proteoliposome fusion and the 
assemblies were characterized with CLSM and confocal-FRAP. Figure 3.4 displays a 
representative PLB with the supported lipid bilayer imaged via DiO (green) and the γ-secretase 
localized via RFP-pHuji (red). Highly homogenous supported bilayers were formed. In this case, 
no significant signs of phase separation were evidenced under these conditions, presumably due 
to the complex mixture of MPs and endogenous lipids that accompany the CHAPSO extraction 
and proteoliposome construction. Figure 3.5 displays a comparison of DiO and RFP FRAP 
performed on the supported bilayers formed on silica microspheres as PLBs.  The red data points 
and fit (right) are from the γ-secretase FRAP and the green data points and fit are from the DiO 
lipid tracer.  The γ-secretase signal yields an effective diffusivity of 0.017 um2/s with a mobile 
fraction of 80%, slightly lower than that obtained from the HEK293 cell. These studies constitute 
the first diffusivity measurements of γ-secretase in supported lipid bilayers.  One aspect of this 
disparity between the live cell diffusivity and lipobead effective diffusivity is the unknown phase 
composition of the lipobead versus the live cell membrane, as shown in the previous chapter the 
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phase mobility is approximately two orders of magnitude different between the two predominant 
phases, Lo and Ld. Another aspect to consider is the effect of interactions between the protein 
and the solid support structure, this interaction is addressed later in this research. However, the 
lipid tracer DiO yields an effective diffusivity of 0.083 um2/s with a mobile fraction of ~80%, 
establishing that the extracted γ-secretase does in fact insert into the intact lipid bilayer of PLB 
constructs, which is well within the range of effective diffusivity from the previous chapter.  
  
Figure 3.2 STED and CLSM microscopy of a HEK293 cell over expressing γ-secretase labeled with 
RFP (as pHuji).  The 3D reconstruction displays a representative HEK293 cell that contains 
overexpressed γ-secretase visualized due to incorporation of the subunit nicastrin-pHuji red fluorescent 
protein (RFP) variant as a C-terminal fusion protein.  Optical sectioning of the 3D cell to isolate the 
plasma membrane localization of γ-secretase is shown in the insets.  A comparison of the same z section 
in CLSM and STED shows the significant resolution increase obtained. 
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Figure 3.3 FRAP analysis of in vivo γ-secretase within the HEK293 cells. This figure shows the 
relative FRAP of the pHuji RFP tagged γ-secretase complex examined within the plasma membrane of 
the HEK293 cell under observation.  This analysis yields an effective diffusivity of ~0.025 µm2/s with a 
mobile fraction of 79% 
 
Figure 3.4 Extracted RFP-tagged γ-secretase reconstituted in PLBs. Reconstituted cell extracts from 
the HEK293 cell containing γ-secretase, obtained using the 1% CHAPSO cellular solubilization method 
typically used to purify the complex from mammalian cells to form proteoliposomes. . The 2:2:1 
DOPC/Sphingomyelin/Cholesterol lipid formulation doped with DiO tracer was used to form liposomes 
that were used to obtain PLBs via fusion, pictured above in 3D reconstructions from the CLSM. In this 
case, no significant signs of phase separation were evidenced under these conditions. Scale bar is 1µm. 
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Figure 3.5 Effective FRAP analysis on RFP and DiO in the HEK293 extract PLBs.  A comparison of 
DiO and RFP FRAP performed on the cell extracts reconstituted on the silica microspheres.  The red data 
points and fit is from the γ-secretase FRAP and the green data points and fit are from is the DiO lipid 
tracer.  The γ-secretase signal yields an effective diffusivity of 0.017 µm2/s with a mobile fraction of 80%, 
and the DiO yields an effective diffusivity of 0.083 µm2/s with a mobile fraction of 80% 
IV. Conclusions 
 Shown here, protein direct insertion into the lipid bilayer is a viable and readily usable 
approach to studying isolated TMPs under controlled conditions.  While these systems are not a 
direct measurement from a biological source, these platforms are comparable as they maintain 
mobility and activity, as seen in various assays performed by the Li lab.  While it has been 
shown that overall diffusion is reduced in these supported bilayer systems, it is possible to 
account for the overall differences between cell and synthetic systems.  This approach can also 
yield reliable and necessary values for future modelling work on these complex spatial reaction-
diffusion protein systems. 
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 The ubiquitous nature of the approach through all of the aforementioned studies leaves 
this as a highly modular and interchangeable system.  This flexibility in design can allow for the 
study of any and all TMPs that can be successfully extracted from cells and reconstituted without 
significant loses.  This approach to TMP study has the potential to revolutionize pharmaceutical 
discovery and trials by allowing for the direct testing of these proteins in controlled lipid 
environments with exact concentration measurements of both enzyme and substrate on a rugged 
platform.  In this system, single protein pathways can be isolated and studied without the use of 
genetically modified and augmented cells, in an environment which maintains biological 
relevance while affording high levels of control and heterogeneity.   
 However, this process is not completely ubiquitous as a few minor changes to the lipid 
formulation, or protein studied can have a marked effect on the effectiveness of this exact 
approach.  Each time a modification would be made, a new cycle of optimization would have to 
be attempted.  In some cases this approach is a tedious downfall of the system, but overall these 
changes are not substantial or large changes, and overall the modifications needed to develop a 
new platform for a different TMP would include finding the proper fluorophore label and what 
concentration range works best for the given microenvironment.  This optimization can be easily 
performed through the use of high throughput screening systems, for which these platforms are 
expressly being developed. 
 This work shows that reproducible, and mass produced, test platforms for TMPs can be 
created simply and reliably.  These platforms are robust, and rugged enough to undergo varying 
forms of mechanical processing such as the washing, to eliminate unfused lipids and non-
inserted or unfolded proteins, up to flow cytometry.  The ability to produce and examine these 
samples in tandem on planar surface and microspheres allows for further characterization of 
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these structures and has advantages over other TMP testing platforms such as GUVs, solubilized 
protein mixtures, or cell culture studies.  γ-secretase proteins and, SB4 and NTM2 substrates, are 
all shown to directly insert into the lipid bilayer and maintain key biological relevancy factors 
such as mobility and phase partitioning.  These platforms also allow for the removal, via 
washing, of key non-biologically relevant substances, such as detergents, which have unknown 
direct effects on these proteins and their structures and interactions. 
V. Tables  
Table 3.1 Additional Materials 
Materials 
Name Atomic Structure Properties 
SB4 
 
APP analogue, 
contains a 
biotinylation and 
FLAG antibody site 
NTM2 
 
 
Notch-1 analogue, 
contains a 
biotinylation site 
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Chapter 4. Tethering modalities 
 I. Introduction 
 In this chapter, the focus is on the use polymer moieties to produce complex yet elegant 
tethering systems.  Tethering is a process by which a solid support structure is chemically 
augmented to both minimize surface interactions between the support and the system it is 
supporting, in this case a lipid bilayer, and provide additional functionality to the solid support.  
It is posited in this work, that functional tethers can be developed and implemented on solid 
silicon dioxide surface for use with a canonical brain cell-analogous lipid structure. The two 
functionalities approached in this work was a tethering modality which fundamentally provided 
the lipid bilayer with numerous anchor points to facilitate a pseudo-binding between the glass 
surface and the bilayer, and a modality which could preferentially sequester proteins which 
express a key binding domain towards the silicon dioxide surface as opposed to the expressing 
this domain outward away from the support.  These two orientations of the protein are facilitated 
by the direct insertion method used in studies explained in an earlier chapter. 
II. Materials and Methods 
 Glass slides, coverslips, and silicon dioxide chips were cleaned overnight in Piranha 
solution, the supports were then washed thoroughly with DI water as stated above.  (3-
Aminopropyl)trimethoxysilane (APTMS) was then mixed to varying concentrations with DI 
water, toluene, and ethanol. In this study the mixtures all contained 5% APTMS v/v within the 
three solvents.  The glass and silicon dioxide surfaces were then immersed in these solutions in 
order to develop a deposited layer of the APTMS solution in a process known as silanization for 
a total of 30 minutes.  One test was performed by placing the clean glass supports in a vacuum 
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chamber with pure APTMS in an open container, the chamber was then placed under a slight 
vacuum, just enough to completely seal the vessel, and let to sit for 30 minutes.  This process 
subsequently leaves a chemically attached amine group on the surface of the solid support.  The 
amine is then used to undergo a series of amine to N-hydroxysuccinimide (NHS) dehydration 
reactions in order to develop a step by step layering of tethering polymers[111]. 
 Specifically used in these studies were varying chain lengths and shapes of poly(ethylene 
glycol) (PEG) polymers purchased from Nanocs, Inc. Also various NHS linkers and conjugates 
were used throughout the studies.  After the silanization step, the supports were then treated with 
either NHS-PEG4-Biotin, NHS-PEG2000-DSPE (DSPE: 1,2-disteroyl-sn-glycero-3-
posphoethanolamine), both at 0.5 mg/ml in DI water, or a solution of a homo-bifunctional 
crosslinker bis(sulfosuccinimidyl)suberate (BS3), at 0.2 mg/ml in DI water.  The BS3 supports 
were then further treated with a solution contained Amine terminated PEG chains of varying 
molecular weights and shapes, at a consistent concentration of 1 mg/ml in DI water.  The most 
predominant linker used in these studies was the 4-arm star PEG polymer at a molecular weight 
of 20,000 Daltons (4armPEG20000-NH2). This star polymer was then capped with one of the 
previously stated capping agents.   
 Biotin and DSPE were chosen to be the tether ends due to their desired functionality 
within the systems studied.  Biotin is a molecule which binds strongly and quickly to the 
molecule Avidin, named due to this high avidity relationship.  In these studies, Streptavidin was 
used as the binder to the adhered biotin molecules.  Streptavidin was chosen due to its innate 
resistance to detergents, which are used primarily in future process described herein.  
Streptavidin conjugates are commercially available, this affords the ability to label and visually 
inspect the degree of tethering, and allows for additional use of the streptavidin-biotin affinity as 
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the streptavidin molecule contains 4 biotin binding domains per molecule.  The DPSE capped 
tether is used for direct insertion in to the lipid membrane.  During tests in which small 
unilamellar vesicles (SUVs) are fused to the surface of these supports, the DPSE lipid can insert 
itself into the lipid bilayer facilitating and promoting vesicle fusion and anchor points to attach 
the bilayer tenuously to the solid support. Figure 4.1 shows the effective modular linking process 
and final product schematics.  
 
 
Figure 4.1 Schematic of effective tethering linkages. This figure shows the effective modular tethering 
support structure, the far left image depicts the base tethering structure of silination of the glass surface 
leaving amine residues followed by a small linking molecule to which a large polymeric moiety is 
attached.  The middle schematic depicts the capping of the previous tether with the lipid anchoring 
functional end piece, while the picture to the right depicts the Biotin expressing functional cap which is 
then further utilized through the introduction of the streptavidin molecule. 
 
Using this system of NHS-Amine ester linkages, allows for the development of a modular 
tethering system, similar to building blocks.  At each consecutive step molecules can be 
introduced, deleted, or augmented in order to develop a more apt tethering moiety for the 
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designed purpose.  This linkage can also be carried out in water without the help of any ancillary 
chemicals to add complexity and potential harm to more delicate platforms, such as biological 
systems.  Tests were performed using various different tethering moieties with this modular 
technique to develop various platforms.  4 arm PEG20000-amine was the predominant second tier 
linker, but other amine-terminated PEG polymers were used throughout this study ranging from 
straight chain polymers, to 8 arm star polymers, from 2kDa up to 20kDa.   
 III. Results and Discussion 
   Throughout these studies, the most important concept for the use of tethering was the 
development of a polymeric cushion on the surface of these solid supports.  Untreated glass and 
silica beads can have varying degrees of roughness on the nano and micron scale, and this 
roughness has the potential of creating diffusion “wells” and barriers which prevent proteins and 
other molecules from properly moving throughout the lipid bilayer, and can even perpetuate the 
coalescence of domains artificially within the bilayer.  As shown in previous work from this 
group, the use of polymer cushions can have a significant effect on the overall diffusivity of 
lipids and proteins within the supported lipid bilayer.  Specifically in the experiments shown 
here, the biotin tag and the DSPE cap were used as added functionalization on top of the 
development of the polymer cushion. 
 The biotin capped samples were the first attempted tethers in this study.  It was the 
original goal of this work to develop a system in which non-biologically relevant protein 
orientations could be sequestered and ultimately removed from the PLB and planar surface 
testing of these TMPs.  Proteins inherently have a specific orientation within the cell, which is 
controlled in vivo during protein transcription, with the extensive use of chaperone proteins and 
directional transcription, proteins maintain their specified orientation within the framework of a 
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cell.  However, in these studies the proteins are reconstituted into synthetic membranes through 
the process of direct insertion.  This method does not yield a constant or specific orientation to 
most of the proteins inserted into the lipid bilayer.  This inevitably means, in any direct insertion 
of proteins into a supported bilayer, that the resulting biomimetic membrane contains a mixture 
of biologically relevant protein orientations as well as the opposite orientation. 
The SB4 and NTM2 substrates used in later tests, developed by collaborators in Dr. 
Yueming Li’s lab at Memorial Sloan-Kettering Cancer Center, contain a built in biotinylation 
site which natively adds a biotin molecule onto the N-terminal side of the protein.  The APP 
molecule also contains a FLAG antibody binding domain on the C-terminal side of the 
transmembrane helix.  This directionality in design was the target of the biotin capped tether 
studies, due to the ability of the streptavidin molecule to bind multiple biotin molecules.  Figure 
4.2 shows the effective development of a tethered glass surface coated with a layer of 
streptavidin which had been conjugated with Alexafluor 660, a red fluorescent molecule.  This 
planar surface was developed by using an APTMS->BS3->4armPEG20000-NH2->NHS-PEG4-
Biotin modular structure, to which a biomimetic lipid bilayer was fused and lipid coated silica 
microspheres were then introduced.  This proof of concept shows that it is possible to develop 
systems containing both planar supported bilayers and lipobeads in tandem as well as the ability 
to label one surface with the biotin capped tether while allowing for the secondary structure, in 
this case the microbead, to contain different functional tether, such as the DSPE capped tether.  
This platform could allow for the sequestration of the non-biologically relevant oriented protein 
by effectively capturing the N-terminal exposed biotin and eliminating the potential for lateral 
diffusion throughout the system.  In this scenario, those proteins with biological orientation 
maintain the ability for lateral diffusion throughout the lipid bilayer and support structure. 
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Figure 4.2 Validation of the Biotin capped tethering modality. This figure is an Amira reconfigured 
3D image taken from a sample in which the glass surface was treated and the biotin expressing tethering 
moiety was developed. A) The isolated red signal shows the coverage of the glass surface with a 
streptavidin molecule which had been conjugated with an Alexafluor 660 fluorophore. B) The greenish-
blue section is a SM/DOPC/cholesterol lipid bilayer containing a lipophilic tracer (DiO) which was fused 
onto both the planar bilayer support as well as microbeads visible in this image.  
The use of tandem planar supported bilayers and lipobead constructs have the potential to 
isolate the proper protein orientation, thus that the improper orientation will diffuse and then 
become pinned on the support containing the streptavidin molecules, and when allowed to reach 
an equilibrium should provide that one support structure contains predominantly relevant 
proteins while the secondary structures contains the oppositely oriented proteins.  The lipobeads 
supports can then be removed from the solid support thus yielding either a planar support or 
lipobead system containing the proteins of interest, depending on the further application of the 
platforms. 
The second approach to tethering came through the DSPE capped tethers in an attempt to 
create a more rugged and robust platform in order to further the possible use in high-throughput 
techniques.  The addition of the DSPE cap onto the polymer cushion using NHS-PEG2000-DSPE 
would allow for the lipid bilayer to essentially contain an anchor point to the solid support 
structure.  In early tests performed on this work, it was seen that the lipid bilayer, when fused 
directly to the solid support structures, was very tenuously adhered to the support structure.  If 
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samples underwent varying forms of stress outside of delicate handling techniques, the result 
could be that the lipid bilayer could wholly or partially slough off of the surface of the support.  
With DSPE lipid inserting itself into the bilayer during the fusion process, and the DPSE 
molecule being chemically attached to the solid support structure, this tethering structure has the 
capacity to relieve stresses on the bilayer by transferring the stresses into the PEG cushion and 
further onto the solid support while maintaining overall mobility of the lipid bilayer. 
A major difficulty of this approach is that there is no visual marker of this tethering 
moiety unlike the tethers using the Alexafluor conjugated to streptavidin, making this DSPE 
capped structure unidentifiable under CLSM.  In order to inspect this tethering moiety AFM was 
used to gather information on the presence of the tethered structure.  Two approaches were taken 
with the AFM, a puncture test using the probe tip to depress through the lipid bilayer and the 
polymer cushion in order to deflect against the solid support beneath, and a tapping imaging 
mode in order to view the intact membrane on the surface of the support.  The puncture test seen 
in figures 4.3 and 4.4, yield distinctive patterns when a lipid bilayer and polymer cushion is 
present on the surface of the planar support structure, as described by Alessandrini et al[112].  
There is a constant, linear force exerted on the tip as it passes through the PBS buffer.  Then, 
close to the support there is a small upward tick in the deflection of the probe tip, followed by a 
small window of undulation, culminating in the linear increase of deflection indicating that the 
solid surface has been reached.  The brief increase in deflection is the tip coming into contact 
with the lipid bilayer, and the undulation following is the tip effectively moving through the 
bilayer and the polymer tether.  The distance of the initial deflection to the steep deflection 
caused by the solid support and the force necessary to break through the bilayer are the important 
characteristics of this test.  The distance between the “infinite force” line and the initial increase 
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in deflection yields the relative height and thickness of the bilayer and polymer cushion together, 
understanding the lipid composition of the bilayer, and estimated thickness can be assumed and 
thus any extraneous distance between initial deflection and the solid support is the relative 
thickness of the polymer cushion.  In the figures below, the effective tether and bilayer 
thicknesses are calculated to be 64.1 ±10.2 nm for the 4-arm PEG 20K sample and 5.6 ±1.6 nm 
for the PEG2000-DSPE tether which is comparable to the results obtained by Hertrich et al[113].  
In this PEG2000 case, the thickness is larger than the Flory radius (3.5 nm). The force obtained 
from this deflection is ultimately the force required to puncture the lipid bilayer fused onto the 
support. It is suggested with this information that a chemically deposited PEG tethering support 
structure was created on the surface of the silica microscope slides. 
 
Figure 4.3 Overlay of indentation tests performed on glass microscope slides containing a 4-arm 
PEG20000 star polymer tether connected to a SM:DOPC:cholesterol lipid bilayer.  Indentation tests 
were performed on a system similar to that shown in figure 4.1 as the lipid tether containing the large 4-
arm PEG20000-NH2 star molecule. Analysis shows that the separation distance from the average 
breakthrough height to the glass surface is approximately 64 nm.  
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Figure 4.4 Overlay of indentation tests performed on glass microscope slides containing a single 
PEG2000-DSPE polymer tether connected to a SM:DOPC:cholesterol lipid bilayer.  Indentation 
studied performed on a system containing only one polymer tether building block, the NHS-Peg2000-DSPE 
only.  These indentation studies show that the average distance between the membrane and the solid 
planar support is approximately 5.6 nm 
Using the tapping imaging mode of the AFM, it is possible to verify the presence of a 
confluent lipid bilayer.   This imaging method converts the received deflection information from 
the AFM probe into a height map of a scanned area.  This height map can then be viewed as an 
image of the surface being scanned by the probe tip, using relative height differences of the 
scanned area it is possible to discern systems of phase separation and individual protein 
molecules imbedded in the lipid bilayer.  Figure 4.5 shows a 3D reconstruction of the tapping 
mode height readout on a glass microscope slide.  It is visible here that the surface roughness of 
microscope slides has a negative impact on the smoothness of the lipid bilayer, even with a 
moderate level of tethering. Phase separation is impossible to determine under these conditions, 
while it is readily apparent on the Ultra-flat thermal oxide wafers.  Coupled with the puncture 
test data, a confluent lipid bilayer can be shown with a given height away from the solid support 
structuring, giving ample evidence of a tethered lipid bilayer system.  The tapping imaging mode 
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of the AFM is used in future studies found here to discern protein partitioning and phase 
separation on planar systems, in order to gain a two-fold approach to understanding the complex 
spatial and diffusive system of γ-secretase and its substrates. 
 
Figure 4.5 3D reconstruction of a tapping mode AFM scan of a glass microscope slide containing a 
4-arm PEG20000 tether connected to a SM:DOPC:cholesterol lipid bilayer. A 3D reconstruction of a 
sample on a silica microscope slide treated with a tethering construct similar to that seen in figure 4.1 the 
lipid tether containing the large 4-arm PEG spacer.  Microscope slides show an incredibly large level of 
roughness on the AFM scale, and at this level simple tethering technique do little to help minimize the 
overall roughness of the support.  
The ultimate goal of this project is to embed γ-secretase and it substrates into these 
systems. Figure 4.6 shows AFM data from the 37ºC reconstitution of γ-secretase into preformed 
sphingomyelin:DOPC:cholesterol (2:2:1) supported bilayers with polymer cushion tethering 
using 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-PEG2000-succinimidyl ester (NHS-
PEG2000-DSPE). Tapping mode image of a PEG2000-DSPE tether supported phase separated lipid 
bilayer with inserted γ-secretase on a thermally oxidized silicon wafer. Panel A is AFM tapping 
mode image obtained from imaging a tether supported SM/DOPC/cholesterol lipid bilayer, with 
inserted γ-secretase proteins.  The liquid ordered and disordered phases of the lipid bilayer can 
be seen here in the two distinct light and dark brown regions. The single star (*) here denotes γ-
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secretase in the Lo phase, while the double star (**) is an indications of a γ-secretase molecule 
suspended in the Ld phase. Panel B is a set of height profiles of features consistent with single γ-
secretase complexes embedded in the tethered bilayer, including the ones indicated with * and ** 
in panel A. A Nicastrin molecular volume of  147 nm3 was obtained using the polymer size 
versus chain length arguments made by Saslowsky et al and the feature size obtained here is 
164±23 nm3, in line with the expected protruding volume of the Nicastrin domain [114].  The 
incorporation levels are lower than desired, however, we will further tune the conditions in future 
experiments. 
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Figure 4.6 Tapping mode image of a PEG2000-DSPE tether supported phase separated lipid bilayer 
with inserted γ-secretase on a thermally oxidized silicon wafer. Panel A is AFM tapping mode image 
obtained from imaging a tether supported SM/DOPC/cholesterol lipid bilayer, with inserted γ-secretase 
proteins.  The liquid ordered and disordered phases of the lipid bilayer can be seen here in the two distinct 
light and dark brown regions. The single star (*) here denotes γ-secretase in the Lo phase, while the 
double star (**) is an indications of a γ-secretase molecule suspended in the Ld phase. Panel B is a set of 
height profiles of features consistent with single γ-secretase complexes embedded in the tethered bilayer, 
including the ones indicated with * and ** in panel A. This analysis yields a feature size of 164±23 nm3 
which is in line with the expected volume of a protruding Nicastrin domain of 147 nm3. 
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IV. Conclusions 
Tethering is a viable, and in some cases necessary, approach to supporting biologically 
relevant synthetic systems.  Tethers promote a more fluid and biologically equivalent system by 
helping to negate any artificial affects caused by the solid support, which are not present in cell 
systems.  Effects ranging from roughness to electrostatic interactions to pinning of a protein 
containing non-negligible intra or extra cellular domains.  Tethering systems also afford the 
ability to functionalize the solid support while not seriously affecting the fluidity or rigidity of 
the synthetic platform. 
It is shown from this work that it is possible to develop tethered support systems using 
straightforward and simple NHS-Amine crosslinker chemistries, which yield highly modular and 
adaptive moieties.  The ends of these moieties can be functionalized to promote various effects 
deemed desirable to the application of these systems.  Shown in this study are the effective 
labelling of the tether moieties, and potential use for protein sequestration, and the process by 
which cushion thickness can be obtained in order to verify the presence of the tethering moiety.   
This work lays the foundation for further exploration into the usefulness and potential 
functionalization for tethered surfaces. In future studies discussed within, AFM is performed on 
two distinct platforms, mica and the glass surfaces described above.  These two platforms are 
vastly different in both charge and roughness which can lead to markedly different systemic 
results and these disparities can be effectively eliminated through the use of tethering.  Mica is 
atomically flat, but contains a high charge density, while the glass surfaces have significantly 
higher roughness but with an overall lower charge density.  The PEG cushion can dampen the 
effects of the surface charge interactions of the mica by creating spatial separation between the 
solid support and the lipid bilayer through which these electrostatic interactions cannot span.  
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The cushion can also minimize the effects of surface roughness on the glass supports by 
essentially filling in the “wells” and normalizing the surface to be a uniform roughness. 
Developing a complimentary tethered system using both supports could allow the qualification 
of using planar glass supports in AFM studies, since currently mica platforms are preferred in 
these studies due to their flatness.  Use of planar glass supports allows for the further edification 
of an in tandem approach of using AFM on planar surfaces to characterize identically treated 
microbead systems, which offers increased capabilities in terms of high throughput techniques 
and other important biological assays. 
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Chapter 5. Conclusions and Future work 
 Throughout this process, highly specialized and biological lipid biomes were researched 
and emulated in order to produce a synthetic, homogeneous, controllable platform on which to 
perform TMP assays for potential use in high-throughput screening and study techniques 
important to the pharmaceutical industry.  TMPs are one of the more difficult family of proteins 
to study and for the development drug modifications, due to the necessity of these proteins to 
remain within a confluent lipid bilayer so as to not denature and lose functionality.  Current 
techniques available for the testing of TMPs on a large scale are not optimized and in some cases 
not possible to be utilized in high-throughput fashion.  Cell culture studies are difficult to 
control, even with techniques such as genetic modification, and in most cases are intensely 
resource heavy to facilitate. Other intact biomembranes approaches such as GUV, 
proteoliposomes, or GPMVs, do not have the specificity or ruggedness to be used in a high-
throughput format or in flow cytometry.  The approaches shown in this work afford a relatively 
simple and effective option containing important factors from these other techniques. 
 Tethering systems are not a predominantly used technique in the field of TMP and lipid 
systems research, due to the fact that most test platforms do not utilize the solid support 
structures on which this research relies.  These solid support structures, microbead and planar 
systems, while a readily viable platform for use in these protein studies as shown, can be 
augmented to more closely resemble and match key characteristics of the biological 
environment.  In previous work it was shown that tethering large PEG moieties onto silica 
surfaces facilitated an environment with a higher overall diffusivity, the work performed herein 
shows that similar tethering moieties can be developed in a modular, building block like 
approach in order to help eliminate surface interactions of the lipid and protein with the solid 
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support, as well as introduce functional molecules onto the ends of these polymer cushion to 
increase overall assay and platform performance. 
 SM:DOPC:cholesterol lipid systems have been widely used as a brain cell analogue in 
various biological and protein studies throughout the past decade.  This system yields a key 
advantage for studying systems such as γ-secretase and its substrates, where under specific 
conditions this lipid formulation forms two distinct semi-miscible phases, liquid ordered and 
disordered.  This phenomenon is highly desirable as it has been shown that effective cholesterol 
levels in cells has an effect on the cleavage efficiency and specificity of proteins like γ-secretase.  
Using this lipid formulation, the work described shows that not only can a confluent lipid bilayer 
be deposited on various solid structures, but also that the effective phase separation can be 
visually studies and quantified.  This aspect of the SM:DOPC:cholesterol lipid formulation is 
indispensable in the study of TMPs as each phase has substantial differences which can have 
marked effects on protein performance as a function of lipid microenvironment.  Understanding 
key factors such as preferential partitioning of proteins, diffusion speed, and activity within 
given environments can readily be obtained with the systems developed.  In addition to the 
SM:DOPC:cholesterol lipid formulation, it is shown that this canonical analogue can be 
modified with more complex lipid structures and cell extracts, yet still maintain this visible and 
quantifiable phase separation. This has led to the development of systems which are much closer 
to biological relevancy in terms of overall lipid environment and yield important spatial 
information about the lipid microenvironment and eventually proteins. 
 Direct protein insertion into a confluent lipid bilayer with the help of specialized 
detergents, namely CHAPSO, is a straightforward a reproducible process on both the planar 
supported bilayer and the lipobeads constructs. The process described in this work affirms the 
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ability to directly insert γ-secretase protein, SB4 and NTM2 substrates into a canonical 
SM:DOPC:cholesterol lipid bilayer.  The insertion of these proteins into the lipobead and planar 
supported bilayer systems allows for the study of apparent phase partitioning of the proteins, 
protein localization, diffusivity, characterization of enzyme and substrate concentrations for 
elucidation of enzyme kinetics, and flow cytometry or other high through-put assays. This work 
was completed on γ-secretase and two of its substrates; however, this process is not restrictive to 
these three proteins.  The procedure and treatment of the proteins in order to insert them into the 
lipid bilayer was not augmented between the three significantly different proteins.  The fact that 
this procedure is unchanged between tests is a positive sign for the possibility of using these 
formulations and this detergent for a wide range of TMPs and other biological moieties which 
require a confluent bilayer in which to be studied in a relevant manner.  
 The experiments performed herein developed a malleable platform on which to perform 
this protein analysis on γ-secretase and its substrates.  It was approached in a way to initially test 
if this process of lipid fusion of the SM:DOPC:cholesterol was applicable to silica microbeads 
and planar bilayers, followed by the introduction of proteins into the platform.  Upon 
determining that this basic approach was valid, the optimization and bilayer changes then 
became a focus.  For this reason, the more complex, doped lipid systems are in early stages of 
development and study to fully understand their usefulness and applicability to the tests 
described.  This however is the first work performed to our knowledge of the development of 
proteolipobead systems with phase separation and lipid configurations with high levels of 
biological relevance, for the use in studying γ-secretase and two of its substrates.  The basic 
system of SM:DOPC:cholesterol displays the ability to reconstitute mobile and active purified 
protein extracts on a platform, shown in previous studies, designed for use in a multitude of high-
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throughput screening studies used heavily in the pharmaceutical industry.  This simplified 
systemic approach is bolstered through the ability to be highly modular along every step of the 
process.  Each step of this work is built for flexibility, from the building block aspect of the 
tethering support structures, to the canonical brain cell analogue, which still retains its beneficial 
qualities, doped with various more complex lipid systems used to model assorted biologically 
relevant lipidomes, and finally to the direct insertion of the γ-secretase and substrates into the 
lipid bilayer, a process which is not specific to the proteins studies and is an ubiquitous approach 
to TMP insertion into membranes.  The tandem approach of studying these systems under both 
CLSM and AFM, while still in its infancy, is a highly effective tool in understanding and 
characterizing the lipid environment and understanding the details and dynamics of the system 
on the nanoscale. 
 Going forward, these systems do require further study and understanding before they are 
deployable test beds for an array of protein testing.  The research here lays the groundwork 
required for the development of model and modular systems, though many more building blocks 
are necessary to develop a full-fledged analytical high-throughput testing modality.   
Firstly, on the topic of tethering, it would be important to understand the effectiveness of 
tethering on solid supports outside of the silica glass based supports tested here.  A litany of 
materials are currently used in biological studies, each could afford a new and unique approach 
to developing tethering moieties with high functionalization, but specifically for this work 
understanding and eliminated the differences between mica and silica surfaces for AFM use 
should minimize the discrepancies seen between the two modalities.  In line with the further 
tethering studies, optimization of the tethering procedure for use on the microbead systems is 
required, all studies in this work were performed on planar silica glass surfaces and all 
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microbead studies did not yield highly reproducible lipobeads constructs.   It would be pertinent 
to know the effect these tethering moieties have on these specific proteins in terms of the PLB 
constructs.  The testing performed in this work primarily focused on the idea of sequestering the 
non-biologically relevant protein orientations in an attempt to eliminate them from any further 
experimental steps and was not continued through the entirety of the research reaching to the 
protein insertion steps.  Similar tethering systems have been studied previously in this lab 
showing that this tethering did not heavily disrupt the protein insertion procedure, so this was 
considered a non-issue throughout this work. 
Secondly, on the topic of confluent lipid bilayers and fusion techniques and fluorescent 
labelling.  This work touches on the a small window of potential modifications to the canonical 
SM:DOPC:cholesterol system, dopants such as BPLE, DSPC, and DPPC studied here are minor 
changes to the core system, however they still build platforms which are arguably very different 
from the lipid micro/nano environment these proteins experience within cell membranes.  
Continual study of relevant cellular lipidomes is necessary to build controllable, simplified, yet 
still relevant biological systems that maintain protein function and are highly relatable to the cell 
functionality.  In this work, the DiO/DiI FRET method was used to understand phase separation, 
lipid mobility, and coverage of the solid supports. This method does have its disadvantages, 
which became apparent throughout this work particularly in that these molecules are a 
predominantly single phase label, these molecules are not STED applicable fluorophores, and 
they take up a large window of the available detector bandwidth.  A complimentary fluorophore 
to label the Lo phase would further validate the work here and help elucidate the two phase 
system.  While Airyscan is an effective and highly functional super resolution method, having 
the ability to validate the phases on two separate systems is beneficial. The combination of the 
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FRET pairing required a detector imaging window from 500-600nm, this window is in the very 
center of the available spectral space.  The proteins tested in this work were all labeled with the 
binding of a conjugated streptavidin to a biotin molecule, this process is straightforward, but as 
shown can contain variance.  Other labeling systems can be studied, including but not limited to 
antibody labeling, genetic modification to include fluorescent proteins, and direct labelling prior 
to protein insertion. 
Finally, on the topic of protein insertion and assays, the protein work completed in this 
research revolved around use in the canonical SM:DOPC:cholesterol lipid formulation, as this 
was the best studied and most optimized formulation throughout the entirety of this work.  This 
lipid formulation while robust and effective, is still only a ternary or pseudo-ternary system 
compared to a biological system with upwards of 10,000 varying components.  Testing of these 
proteins in the doped samples developed in this work could be useful in elucidating whether 
these more complex systems will be more effective in understanding the protein functionality in 
cell systems and verify a correlation between these developed synthetic systems and the cellular 
environments in which these proteins reside.  Also suggested would be the testing of these 
proteins on more tethered surfaces, both in complexity and in structure. Furthermore, testing of 
this direct insertion method using the CHAPSO detergent on other more variable protein will 
determine the extent of use. γ-secretase is a multi-subunit with 19 helical passes through the lipid 
bilayer, while both APP and Notch-1 are comprised of a single helical pass through the bilayer 
with both intracellular and extracellular extremities. This range in proteins tested does suggest 
that a large variety of TMPs would follow the same pattern of facilitated insertion into the 
lipobead systems, however variations in size of the transmembrane portion, large or highly 
charged extra/intra cellular domains, and varying secondary/tertiary/quaternary structures of 
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TMPs may impose further difficulties on this procedure.  In the case of studying a wider range of 
proteins, this aspect is closely tied with the further development and optimization of a wider 
variety of synthetic membrane analogues.  Together the eventual goal of this work is to build a 
catalog of proteins and lipid membrane analogs which can be selected and prepared readily to 
closely mimic a highly reproducible biologically relevant environment through close control and 
synthetic means.   
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